<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s11671-019-3019-6</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="review-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">11671</journal-id><journal-id journal-id-type="doi">10.1007/11671.1556-276X</journal-id><journal-title-group><journal-title>Nanoscale Research Letters</journal-title><abbrev-journal-title abbrev-type="publisher">Nanoscale Res Lett</abbrev-journal-title></journal-title-group><issn pub-type="ppub">1931-7573</issn><issn pub-type="epub">1556-276X</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s11671-019-3019-6</article-id><article-id pub-id-type="manuscript">3019</article-id><article-id pub-id-type="doi">10.1186/s11671-019-3019-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Nano Review</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Magnetic Functionalized Nanoparticles for Biomedical, Drug Delivery and Imaging Applications</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Anderson</surname><given-names>Simon D.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0363-8168</contrib-id><name><surname>Gwenin</surname><given-names>Vanessa V.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au3"><name><surname>Gwenin</surname><given-names>Christopher D.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs1167101930196_cor3">c</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000118820937</institution-id><institution-id institution-id-type="GRID">grid.7362.0</institution-id><institution content-type="org-division">School of Natural Sciences, College of Environmental Sciences and Engineering</institution><institution content-type="org-name">Bangor University</institution></institution-wrap><addr-line content-type="postcode">LL57 2UW</addr-line><addr-line content-type="city">Bangor</addr-line><country country="GB">UK</country></aff></contrib-group><author-notes><corresp id="IDs1167101930196_cor3"><label>c</label><email>c.d.gwenin@bangor.ac.uk</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>5</month><year>2019</year></pub-date><pub-date date-type="pub" publication-format="print"><month>12</month><year>2019</year></pub-date><volume>14</volume><issue seq="188">1</issue><elocation-id>188</elocation-id><history><date date-type="registration"><day>17</day><month>5</month><year>2019</year></date><date date-type="received"><day>4</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>17</day><month>5</month><year>2019</year></date><date date-type="online"><day>30</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>Â© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><p id="Par1">Medicine is constantly looking for new and improved treatments for diseases, which need to have a high efficacy and be cost-effective, creating a large demand on scientific research to discover such new treatments. One important aspect of any treatment is the ability to be able to target only the illness and not cause harm to another healthy part of the body. For this reason, metallic nanoparticles have been and are currently being extensively researched for their possible medical uses, including medical imaging, antibacterial and antiviral applications. Superparamagnetic metal nanoparticles possess properties that allow them to be directed around the body with a magnetic field or directed to a magnetic implant, which opens up the potential to conjugate various bio-cargos to the nanoparticles that could then be directed for treatment in the body. Here we report on some of the current bio-medical applications of various metal nanoparticles, including single metal nanoparticles, functionalized metal nanoparticles, and core-shell metal nanoparticles using a core of Fe<sub>3</sub>O<sub>4</sub> as well as synthesis methods of these core-shell nanoparticles.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Nanoparticle</kwd><kwd>Drug delivery</kwd><kwd>Nanoparticle synthesis</kwd><kwd>Nanomedicine</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Springer</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>5</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>17</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/11671_2019_Article_3019.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>ReviewPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Materials Science</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nanotechnology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nanotechnology and Microengineering</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nanoscale Science and Technology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Nanochemistry</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Molecular Medicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Chemistry and Materials Science</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par35">Metal nanomaterials represent a significant doorway for the future of medicine. Although there is still much unknown about the long-term safety of metal nanoparticles in medicine [<xref ref-type="bibr" rid="CR1">1</xref>], these particles have already found their place within various biomedical applications such as site-specific imaging in vivo [<xref ref-type="bibr" rid="CR2">2</xref>â<xref ref-type="bibr" rid="CR4">4</xref>], cancer detection [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], cancer therapy [<xref ref-type="bibr" rid="CR7">7</xref>â<xref ref-type="bibr" rid="CR10">10</xref>], neurodegenerative disease therapy [<xref ref-type="bibr" rid="CR11">11</xref>â<xref ref-type="bibr" rid="CR13">13</xref>], HIV/AIDS therapy [<xref ref-type="bibr" rid="CR14">14</xref>â<xref ref-type="bibr" rid="CR16">16</xref>], ocular disease therapy [<xref ref-type="bibr" rid="CR17">17</xref>â<xref ref-type="bibr" rid="CR19">19</xref>], and respiratory disease therapy [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. FigureÂ <xref rid="Fig1" ref-type="fig">1</xref> presents a range of current uses for nanoparticles in medicine. Despite the recent advances in nanomedicine, there are still many obstacles in the way of nano-therapy, such as it can be hard to achieve a synthesis route which produces easily repeatable results, with many nanoparticle synthesis methods producing a range in both size [<xref ref-type="bibr" rid="CR22">22</xref>â<xref ref-type="bibr" rid="CR24">24</xref>] and shape [<xref ref-type="bibr" rid="CR25">25</xref>â<xref ref-type="bibr" rid="CR28">28</xref>] of nanoparticles and/or do not produce the nanomaterials in a large enough quantity to make it economically viable [<xref ref-type="bibr" rid="CR29">29</xref>]. Another key factor is that it is relatively unknown as to the long-term toxicity of some nanoparticles over a period of time due to how relatively new the field of research is [<xref ref-type="bibr" rid="CR30">30</xref>â<xref ref-type="bibr" rid="CR32">32</xref>]. Among the many possible uses of metal nanoparticles lies the area of drug delivery [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Due to the large surface area that nanoparticles provide [<xref ref-type="bibr" rid="CR35">35</xref>], they possess the ability to be able to deliver large quantities of drugs or other medical cargoes [<xref ref-type="bibr" rid="CR36">36</xref>]. An alternative to single metal nanoparticles is to incorporate a core to the nanoparticle which has alternative properties to the shell material, and one example of this is to incorporate a magnetic core. One challenge that still presents itself is synthesizing core-shell nanoparticles; there are many ways to synthesize nanoparticles [<xref ref-type="bibr" rid="CR37">37</xref>], but new challenges emerge when attempting to synthesize a core-shell nanoparticle [<xref ref-type="bibr" rid="CR38">38</xref>].<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Some of the current uses of nanoparticles in medicine</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/11671_2019_3019_Fig1_HTML.png" id="MO1"/></p></fig></p><p id="Par36">This review first focuses on some of the methods currently used to generate core-shell nanoparticles focusing on using cores of Fe<sub>3</sub>O<sub>4</sub> and coatings of gold or silver. We then examine current bio-medical applications of single metal nanoparticles, their limitations, and how to overcome them with the application of magnetic cores.</p></sec><sec id="Sec2"><title>Synthesis of Core-Shell Nanoparticles</title><p id="Par37">Methods for the synthesis of metallic nanoparticles have been known for many years, for example, Stevenson et al. published a synthesis for gold nanoparticles via the reduction of HAuCl<sub>4</sub> in 1951 [<xref ref-type="bibr" rid="CR39">39</xref>]. Since then, there have been many different routes for nanoparticle synthesis such as gas deposition [<xref ref-type="bibr" rid="CR40">40</xref>], sol-gel [<xref ref-type="bibr" rid="CR41">41</xref>], and aerosol/vapor phase [<xref ref-type="bibr" rid="CR42">42</xref>]. However, a new challenge presents itself when attempting to synthesize metal nanoparticles consisting of a core-shell structure, in which one metal forms the core and a second metal forms the shell, for example Fe particles degrade in water, whilst HAuCl<sub>4</sub> is a strong oxidizing agent [<xref ref-type="bibr" rid="CR38">38</xref>]. One such example that will be discussed further is using a Fe<sub>3</sub>O<sub>4</sub> (iron oxide) core and gold as the coating shell. In the preparation of such core-shell metal nanoparticles, two of the biggest issues are attempting to control the rate of coating and controlling the uniformity of the coating to create a solution of nanoparticles which are all of very similar shape and size [<xref ref-type="bibr" rid="CR43">43</xref>]. Coating of gold or silver onto an iron oxide core can be divided into two main categories: direct coating of gold/silver onto iron [<xref ref-type="bibr" rid="CR44">44</xref>] or using an intermediary layer to act as a glue between the gold and the iron layer [<xref ref-type="bibr" rid="CR45">45</xref>]. The former category will be discussed here. The following text describes some methods that have been devised to synthesize gold- and silver-coated Fe<sub>3</sub>O<sub>4</sub> nanoparticles.</p><sec id="Sec3"><title>Reverse Micelle Synthesis</title><p id="Par38">A popular route for synthesizing metal nanoparticles is to use the reverse micelle method, or sometimes called the microemulsion route [<xref ref-type="bibr" rid="CR46">46</xref>]. This method was first introduced in the 1980s when colloidal solutions of rhodium, platinum, and palladium nanoparticles were first synthesized [<xref ref-type="bibr" rid="CR47">47</xref>].</p><p id="Par39">Micelles are formed when molecules with hydrophobic and hydrophilic constituent parts come into contact with either an aqueous or hydrophobic phase [<xref ref-type="bibr" rid="CR48">48</xref>]. The micelles will organize themselves in such a way that allows the hydrophilic part to be in contact with the aqueous phase and the hydrophobic constituent facing the hydrophobic phase [<xref ref-type="bibr" rid="CR49">49</xref>]. In essence, a spheroid is formed with an inner shielded phase, which can furthermore contain a cargo [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR50">50</xref>â<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par40">There are different approaches to the microemulsion route and these include water-in-oil (w/o) [<xref ref-type="bibr" rid="CR53">53</xref>] and water-in-supercritical CO<sub>2</sub> (w/sc-CO<sub>2</sub>) [<xref ref-type="bibr" rid="CR54">54</xref>]. A w/o emulsion occurs when water is dispersed in a hydrocarbon-based continuous phase [<xref ref-type="bibr" rid="CR53">53</xref>], thermodynamically driven surfactant self-assembly, and then generates the reverse micelles, with spherical micelles being the most common shape [<xref ref-type="bibr" rid="CR43">43</xref>]. Any added polar or ionic materials added to this mixture become compartmentalized within the micelles, and nanoparticles are then formed when the micelle membranes come into contract with each other through Brownian motion [<xref ref-type="bibr" rid="CR55">55</xref>]. A w/sc-CO<sub>2</sub> emulsion involves using a fluid (CO<sub>2</sub>) that is in a supercritical state, i.e., above both its critical pressure and temperature [<xref ref-type="bibr" rid="CR56">56</xref>]. This method holds particular interest as it is a more âgreenâ approach to nanoparticle synthesis as no toxic organic solvents are required. It is also easier to recoup the product by simply lowering the pressure and releasing the fluid as CO<sub>2</sub> gas [<xref ref-type="bibr" rid="CR57">57</xref>].</p><p id="Par41">The reverse micelle route has been adapted from synthesizing metal nanoparticles to coating previously synthesized nanoparticles [<xref ref-type="bibr" rid="CR58">58</xref>]. The first gold-coated iron oxide (Au-Fe<sub>3</sub>O<sub>4</sub>) nanoparticles synthesized in reverse micelles were done so almost 20âyears ago [<xref ref-type="bibr" rid="CR59">59</xref>]. This synthesis of Au-Fe<sub>3</sub>O<sub>4</sub> nanoparticles was done using a H<sub>2</sub>O/CTAB (cetyltrimethyl ammoniumbromide) system to produce the micelles with sodium borohydride (NaBH<sub>4</sub>) as the reducing agent, reducing gold chloride (HAuCl<sub>4</sub>) onto the iron core. This synthesis produced a nanoparticle dispersion with an average size of 12ânm. Since this is the first production of Au-Fe<sub>3</sub>O<sub>4</sub> NPs using microemulsions, there has been a range of Au-Fe<sub>3</sub>O<sub>4</sub> NPs synthesis routes discovered [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR60">60</xref>â<xref ref-type="bibr" rid="CR63">63</xref>]. FigureÂ <xref rid="Fig2" ref-type="fig">2</xref> is a generic representation of how the nanoparticles are formed using the reverse micelle route.<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>A generic representation of the interaction of reverse micelles containing salts the react to form metal nanoparticles</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/11671_2019_3019_Fig2_HTML.png" id="MO2"/></p></fig></p><p id="Par42">Lin et al. published a slightly modified method to coat Fe<sub>3</sub>O<sub>4</sub> with gold using a reverse micelle method [<xref ref-type="bibr" rid="CR60">60</xref>]. The synthesis also employs a system using CTAB as the surfactant to form the reverse micelle, but with 1-butanol as a co-surfactant and octane as the oil phase, adding a water solution containing the metal ions using NaBH<sub>4</sub> to reduce HAuCl<sub>4</sub> onto the surface of the iron oxide nanoparticles. The reported optical results of the coated particles showed a shift in the absorbance peak of the UV/vis spectra from the gold colloid (526ânm) to the Au-Fe<sub>3</sub>O<sub>4</sub> (555ânm). The TEM results of the coated particles indicated a size distribution of 5â15ânm, with an average size of 10ânm. This method was repeated by Pana et al. with a slightly larger size distribution of 5â35-nm-sized Au-Fe<sub>3</sub>O<sub>4</sub> nanoparticles [<xref ref-type="bibr" rid="CR63">63</xref>]. In addition, a very similar system has been employed by Seip et al. with the exception of using hydrazine to reduce the HAuCl<sub>4</sub> [<xref ref-type="bibr" rid="CR64">64</xref>].</p><p id="Par43">The coating of Fe<sub>3</sub>O<sub>4</sub> nanoparticles is not limited to just gold; Lopez Perez et al. reported on the synthesis of iron oxide nanoparticles using a system containing cyclohexane/Brij-97 (co-surfactant) and an aqueous phase with iron salts of FeSO<sub>4</sub>.7H<sub>2</sub>O and FeCl<sub>3</sub>.6H<sub>2</sub>O [<xref ref-type="bibr" rid="CR65">65</xref>]. This system has been coated with both silver [<xref ref-type="bibr" rid="CR58">58</xref>] and gold [<xref ref-type="bibr" rid="CR46">46</xref>], producing 13-nm particles. An alternative method is reported by Tamer et al. for the synthesis of Au-Fe<sub>3</sub>O<sub>4</sub> nanoparticles [<xref ref-type="bibr" rid="CR62">62</xref>]. This method employs a co-precipitation of iron salts in NaOH, which were then washed in HClO<sub>4</sub> to produce oxidized Fe<sub>3</sub>O<sub>4</sub> nanoparticles. Coating of gold onto the Fe<sub>3</sub>O<sub>4</sub> NPs occurred via the reduction of HAuCl<sub>4</sub> by NaOH delivered to the system by CTAB micelles. Au-Fe<sub>3</sub>O<sub>4</sub> NPs were produced with an average size of 23.5ânm. After characterization, particles were then modified with various functional groups to form a self-assembled monolayer (SAM) and further used for the capturing and detection of <italic>Escherichia coli</italic>.</p><p id="Par44">A modified version of the reverse micelle synthesis has been done by Zhang et al. involving the use of a laser as the initiator for the coating of iron nanoparticles with gold [<xref ref-type="bibr" rid="CR66">66</xref>]. The process involves making a reaction mixture of iron nanoparticles encapsulated in CTAB micelles, gold nanopowder in water, and octane, then irradiating with a pulsed laser while vigorously stirring the reaction. The laser irradiation facilitates the thermal decomposition of the gold nanoparticles. Gold atoms and clusters formed around the iron nanoparticles, forming gold-coated iron nanoparticles. The TEM results for the Au-Fe nanoparticles synthesized this way gave an average size of 18ânm with a size distribution of Â±36ânm.</p></sec><sec id="Sec4"><title>Thermal Synthesis</title><p id="Par45">Among the various methods of gold shell-iron core nanoparticle synthesis lies a thermal route, wherein the reaction involves heating the reaction mixture to above its boiling point [<xref ref-type="bibr" rid="CR67">67</xref>], and sometimes refluxing [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. There are two main categories for this type of synthesis: hydrothermal (water-based solvent) [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>] and solvothermal (organic-based solvent) [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. While there are many techniques for synthesizing metal nanoparticles via the thermal route [<xref ref-type="bibr" rid="CR73">73</xref>â<xref ref-type="bibr" rid="CR78">78</xref>], it is not possible to achieve the synthesis of the cores and coating of gold in a one pot reaction [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR79">79</xref>â<xref ref-type="bibr" rid="CR81">81</xref>], and in some cases, Fe<sub>3</sub>O<sub>4</sub> cores are synthesized via a reverse micelle route [<xref ref-type="bibr" rid="CR70">70</xref>] or a colloidal route [<xref ref-type="bibr" rid="CR78">78</xref>] and then the particles are coated using a hydro- or solvothermal technique [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. While there are a variety of solvent systems that are used in these synthetic methods, the majority of routes involve the addition of either iron oxide nanoparticles to boiling HAuCl<sub>4</sub> or the inverse of HAuCl<sub>4</sub> being added to boiling solutions of iron oxide nanoparticles [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR79">79</xref>].</p><p id="Par46">A method for the synthesis of Au-Fe<sub>3</sub>O<sub>4</sub> nanoparticles has been done by Rudakovskaya et al. via a hydrothermal technique [<xref ref-type="bibr" rid="CR76">76</xref>]. The principle of the method follows the addition of Fe<sub>3</sub>O<sub>4</sub> nanoparticles to a boiling HAuCl<sub>4</sub> solution. TEM analysis of these nanoparticles indicated an average size of 30ânm, with a general spherical shape and a size distribution between 20 and 35ânm; these images can be seen in Fig.Â <xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>A TEM image of the nanoparticles synthesized by Rudakovskaya et al. As can be seen, the nanoparticles are roughly spherically shaped with an average size of 30ânm [<xref ref-type="bibr" rid="CR76">76</xref>]</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/11671_2019_3019_Fig3_HTML.png" id="MO3"/></p></fig></p></sec><sec id="Sec5"><title>Colloidal Synthesis</title><p id="Par47">Colloidal synthesis techniques offer a simple yet effective way of synthesizing metal nanoparticles [<xref ref-type="bibr" rid="CR82">82</xref>]. Colloidal techniques often offer a level of simplicity over other techniques for nanoparticle synthesis, without the need for different solvents, or that it can be carried out at room temperature [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. The basic principles of the synthesis involve dispersing different metal ions in an aqueous phase, adding a reducing agent to the mixture, then mixing at a controlled temperature to form insoluble nanoparticles [<xref ref-type="bibr" rid="CR39">39</xref>]. Colloidal synthesis routes offer the benefit of not having to involve potential toxic solvents in the synthesis (ideal if the nanoparticles are intended for biological use). However, there are some limitations to colloidal routes such as it can be hard to control the size distribution of the final synthesized nanoparticles [<xref ref-type="bibr" rid="CR85">85</xref>] and the shape of the nanoparticles can be heavily influenced by reagent concentration [<xref ref-type="bibr" rid="CR85">85</xref>]. On the positive side, it can however be easier to produce nanoparticles in a larger quantity [<xref ref-type="bibr" rid="CR86">86</xref>]. This method for metal nanoparticle synthesis has been around for many years, being used for the synthesis of different types of nanoparticles such as silver [<xref ref-type="bibr" rid="CR87">87</xref>] and gold [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR88">88</xref>].</p><p id="Par48">This basic method has been advanced and developed to produce different synthetic routes for the formation of gold-coated iron oxide nanoparticles [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR89">89</xref>â<xref ref-type="bibr" rid="CR97">97</xref>]. Most of the methods for the synthesis of gold-coated iron oxide revolve around using various reducing agents to reduce HAuCl<sub>4</sub> onto the surface of the iron oxide. Nadagouda et al. offer a proposed âgreenâ synthetic route, using ascorbic acid to reduce HAuCl<sub>4</sub> [<xref ref-type="bibr" rid="CR84">84</xref>]<sub>.</sub> This method however seems to show little to no control over size or shape of the coated nanoparticles due to the lack of capping agent (an agent that binds to the outside of the nanoparticle that stops further âgrowthâ of the nanoparticle) used in the synthesis [<xref ref-type="bibr" rid="CR98">98</xref>]. A method which does show more control over the shape and size of synthesized coated particles is presented by Pal et al. [<xref ref-type="bibr" rid="CR95">95</xref>] This method employs gold acetate as the gold salt, which is reduced onto the surface of 6-nm Fe<sub>3</sub>O<sub>4</sub> nanoparticles to create 7-nm-sized AuâFe<sub>3</sub>O<sub>4</sub> particles, which are spherical in shape. A rapid method for coating Fe<sub>3</sub>O<sub>4</sub> nanoparticles is presented by Rawal et al. which involves dispersing Fe<sub>3</sub>O<sub>4</sub> nanoparticles in a solution of HAuCl<sub>4</sub>, then mixing with ethanol [<xref ref-type="bibr" rid="CR83">83</xref>]. After 15âmin at room temperature, the reaction was stopped and the Au-Fe<sub>3</sub>O<sub>4</sub> nanoparticles were then separated with a magnet. TEM analysis of the purified solution showed that the particles produced ranged in size from 30 to 100ânm and had varied shapes across the sample; these images can be seen in Fig.Â <xref rid="Fig4" ref-type="fig">4</xref>. While this synthesis technique produced the coated nanoparticles quickly, it does not appear to be a very efficient synthesis for production of uniformly shaped and sized particles [<xref ref-type="bibr" rid="CR83">83</xref>].<fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>A TEM image of the nanoparticles synthesized by Rawal et al. These nanoparticles have a size distribution of 20â100ânm [<xref ref-type="bibr" rid="CR83">83</xref>]</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/11671_2019_3019_Fig4_HTML.png" id="MO4"/></p></fig></p><p id="Par49">While some techniques offer just the reduction of gold salts, others prefer to put the reducing agent onto the surface of the iron, such as hydroxylamine [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. In many cases when Fe<sub>3</sub>O<sub>4</sub> nanoparticles are coated with gold, the reduction of a gold salt yields standard gold nanoparticles as well [<xref ref-type="bibr" rid="CR74">74</xref>], so the addition of the reducing agent onto the surface of the iron nanoparticles aims to improve the efficiency of the coating and is intended to lower the quantity of gold nanoparticles produced as a by-product [<xref ref-type="bibr" rid="CR93">93</xref>].</p><p id="Par50">Another technique involves seeding gold onto the surface of magnetic nanoparticles which provides a more direct route of getting gold to nucleate around the magnetic core of the nanoparticles [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. This technique involves binding gold seeds, which are smaller than the iron oxide nanoparticles in solution, to the surface of the iron oxide. When the HAuCl<sub>4</sub> is reduced in solution, the Au<sup>+</sup> ions will seed onto the iron oxide and form a shell around the iron oxide nanoparticles. This gold seeding has been successfully employed by several groups; Goon et al. used polyethyleneimine to control the seeding of gold onto the surface of Fe<sub>3</sub>O<sub>4</sub>, producing fully coated nanoparticles. [<xref ref-type="bibr" rid="CR91">91</xref>] However, the synthesized Au-Fe<sub>3</sub>O<sub>4</sub> particles displayed high polydispersity, with particle size ranging from 40 to 110ânm. Levin et al. managed to produce gold shell-magnetic core nanoparticles with a size range of 50â70ânm, using a core functionalized with organosilane molecules to bind to the gold seeds [<xref ref-type="bibr" rid="CR92">92</xref>]. Seeding of gold nanoparticles onto an iron core can be demonstrated with a variety of core shapes, for example, Wang et al. demonstrated gold seeding onto rice-shaped âNano riceâ Fe<sub>3</sub>O<sub>4</sub> structures, which then led to a complete thick gold shell when gold was reduced onto the surface [<xref ref-type="bibr" rid="CR97">97</xref>].</p></sec></sec><sec id="Sec6"><title>Bio-Medical Applications of Metal Nanoparticles</title><sec id="Sec7"><title>Antimicrobial Agents</title><p id="Par51">Bacterial infections are very common, with antibiotics being a primary method of treatment since the discovery of penicillin in 1928 by Alexander Fleming [<xref ref-type="bibr" rid="CR99">99</xref>]. Nanomedicine provides us with a new, broad range of possible treatment modalities, with metal nanoparticles being explored for future treatments [<xref ref-type="bibr" rid="CR100">100</xref>]. TableÂ <xref rid="Tab1" ref-type="table">1</xref> lists some of the nanoparticles that have been explored for antimicrobial applications. One material that has been examined for its potential use is silver, which has shown to have a variety of biomedical uses [<xref ref-type="bibr" rid="CR101">101</xref>], for example, Sreekumar et al. utilized silver nanoparticles as part of a network of antimicrobial fibers. The nanoparticles varied in size from 20 to 120ânm, with an antibacterial efficacy against <italic>Escherichia coli</italic> as high as 94.3% compared to the fibers without silver nanoparticles [<xref ref-type="bibr" rid="CR102">102</xref>]. While it has been shown that an antibiotic such as ampicillin is capable at achieving a kill rate of â¤â99.9% in <italic>E. coli</italic> [<xref ref-type="bibr" rid="CR103">103</xref>], the same study also reported the emergence of resistance to ampicillin in certain strains of <italic>E. coli</italic>. On this same note, it has been reported that <italic>E. coli</italic> can develop a resistance to silver nanoparticles; however, this resistance is not a genetic change, but it is a physical response that attempts to cause the colloidal nanoparticles to aggregate [<xref ref-type="bibr" rid="CR104">104</xref>]. Also employing silver for its antibacterial properties, Holtz et al. designed a system of 60-nm silver vanadate nanowires âdecoratedâ with silver nanoparticles with a diameter of 1â20ânm [<xref ref-type="bibr" rid="CR105">105</xref>]. This system showed to be promising against three <italic>Staphylococcus aureus</italic> strains and also interestingly had a much lower growth inhibiting concentration against methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) than the antibiotic oxacillin.<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>List of antibacterial properties that have been exhibited by some metal nanoparticles and metal nanoparticle conjugates</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Type of nanoparticle</p></th><th><p>Size (nm)</p></th><th><p>Antimicrobial application</p></th><th><p>Mechanism of action</p></th><th><p>Ref</p></th></tr></thead><tbody><tr><td><p>Silver as part of network of fibers</p></td><td><p>20â120</p></td><td><p><italic>E. coli</italic></p></td><td><p>Bacterial growth inhibition</p></td><td><p>[<xref ref-type="bibr" rid="CR102">102</xref>]</p></td></tr><tr><td><p>Silver vanadate nanowires</p></td><td><p>1â20</p></td><td><p><italic>S. aureus</italic></p></td><td><p>Bacterial growth inhibition</p></td><td><p>[<xref ref-type="bibr" rid="CR105">105</xref>]</p></td></tr><tr><td><p>Naked silver</p></td><td><p>10â25</p></td><td><p><italic>C. albicans</italic>, <italic>P. fluorescens</italic>, <italic>E. coli</italic></p></td><td><p>Bacterial growth inhibition</p></td><td><p>[<xref ref-type="bibr" rid="CR106">106</xref>]</p></td></tr><tr><td><p>Thioguanine-capped gold</p></td><td><p>3â4</p></td><td><p><italic>E. coli</italic>, <italic>A. fumigatus</italic>, <italic>P. aeruginosa</italic>, and anticancer effect against Hep2</p></td><td><p>Bacterial growth inhibition, cellular toxicity</p></td><td><p>[<xref ref-type="bibr" rid="CR107">107</xref>]</p></td></tr><tr><td><p>Naked gold</p></td><td><p>25</p></td><td><p><italic>C. pseudotuberculosis</italic></p></td><td><p>Vacuole formation in cell wall and agglomeration of NPs within cells</p></td><td><p>[<xref ref-type="bibr" rid="CR108">108</xref>]</p></td></tr><tr><td><p>Naked gold</p></td><td><p>6â40</p></td><td><p><italic>S. aureus</italic>, <italic>K. pneumonia</italic>, <italic>B. subtilis</italic></p></td><td><p>Bacterial growth inhibition</p></td><td><p>[<xref ref-type="bibr" rid="CR109">109</xref>]</p></td></tr></tbody></table></table-wrap></p><p id="Par52">A silver nanoparticle synthesis was reported by Verma et al. where they employed their nanoparticles against the bacteria: <italic>Pseudomonas fluorescens</italic>, <italic>E. coli</italic>, and the fungus <italic>Candida albicans</italic> [<xref ref-type="bibr" rid="CR106">106</xref>]. The silver nanoparticles had an average minimum inhibitory growth concentration of 5.83âÎ¼g/ml across the three strains, compared to some commonly used antibiotics such as ampicillin and neomycin which have minimum inhibitory growth concentrations of 4.0âÎ¼g/ml and 16.0âÎ¼g/ml, respectively, against strains of <italic>E. coli</italic> [<xref ref-type="bibr" rid="CR110">110</xref>]. Of potential interest is the properties the nanoparticles displayed against <italic>P. fluorescens</italic> an <italic>C. albicans</italic>, both of which are associated with causing disease in immunocompromised patients [<xref ref-type="bibr" rid="CR111">111</xref>]. Further investigations might find that the silver nanoparticles are a more efficient way to treat the pathogens than some of the most commonly used antibiotics, such as amphotericin B, which has extensive side effects [<xref ref-type="bibr" rid="CR112">112</xref>].</p><p id="Par53">The synthesis of thioguanine-capped gold nanoparticles has been reported by Selvaraj et al. where an enhanced antimicrobial effect against several bacterium, including: <italic>E. coli</italic>, <italic>Aspergillus fumigatus</italic>, and <italic>Pseudomonas aeruginosa</italic> [<xref ref-type="bibr" rid="CR107">107</xref>]. It was found that the thioguanine-capped gold nanoparticles were more effective than unconjugated thioguanine as anticancer and antimicrobial agents, with their activities showing potential use as carriers for cancer drugs. In a similar manner, gold nanoparticles have been reported to have an antimicrobial effect on <italic>Corynebacterium pseudotuberculosis</italic> [<xref ref-type="bibr" rid="CR108">108</xref>], nanoparticles with an average size of 25ânm, using a dose of 50âÎ¼g/ml showed a bacterial growth inhibition of 95% after 20âmin of exposure. Similarly, naked gold nanoparticles were shown to have an antimicrobial effect on a variety of gram negative and gram positive bacteria including <italic>S. aureus</italic>, <italic>Klebsiella pneumonia</italic>, and <italic>Bacillus subtilis</italic> [<xref ref-type="bibr" rid="CR109">109</xref>]. A dose of 1.35âÎ¼g/ml of AuNPs showed a growth inhibition of 46.4Â±0.4%, 38.3Â±0.2%, and 57.8Â±0.2% for <italic>S. aureus</italic>, <italic>K. pneumonia</italic>, and <italic>B. subtilis</italic>, respectively.</p></sec><sec id="Sec8"><title>Antiviral</title><p id="Par54">As with antibacterial applications, metal nanoparticles have shown to be promising in antiviral applications; TableÂ <xref rid="Tab2" ref-type="table">2</xref> demonstrates a range of nanoparticles that have been shown to possess antiviral properties and could potentially be applied when treating viruses. Both naked and coated silver nanoparticles [<xref ref-type="bibr" rid="CR113">113</xref>â<xref ref-type="bibr" rid="CR116">116</xref>] have been shown to have a range of antiviral applications when in the nano-scale range.<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Some of the metal nanoparticles and metal nanoparticle conjugates that have been demonstrated as having antiviral properties</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Type of nanoparticle</p></th><th><p>Size (nm)</p></th><th><p>Antiviral application</p></th><th><p>Mechanism of action</p></th><th><p>Ref</p></th></tr></thead><tbody><tr><td><p>AgNPs</p></td><td><p>10â50</p></td><td><p>Hepatitis B virus (HBV)</p></td><td><p>Interaction with DNA and/or binding with virus particles</p></td><td><p>[<xref ref-type="bibr" rid="CR113">113</xref>]</p></td></tr><tr><td><p>Ag-PS-NPs</p></td><td><p>10â80</p></td><td><p>Monkeypox virus (MPV)</p></td><td><p>Blocking of virus-host cell binding and penetration</p></td><td><p>[<xref ref-type="bibr" rid="CR114">114</xref>]</p></td></tr><tr><td><p>PVP-AgNPs</p></td><td><p>30â50</p></td><td><p>Human immunodeficiency virus type 1 (HIV-1)</p></td><td><p>Prevention of HIV-1 transfection</p></td><td><p>[<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]</p></td></tr><tr><td><p>Au-MES</p></td><td><p>4</p></td><td><p>Herpes simplex virus type 1 (HSV-1)</p></td><td><p>Competition with host cell binding</p></td><td><p>[<xref ref-type="bibr" rid="CR117">117</xref>]</p></td></tr><tr><td><p>Gold coated with an amphiphilic sulfate ligand</p></td><td><p>2</p></td><td><p>Human immunodeficiency virus type 1 (HIV-1)</p></td><td><p>Binding to gp120</p></td><td><p>[<xref ref-type="bibr" rid="CR118">118</xref>]</p></td></tr><tr><td><p>Copper iodide (CuI) nanoparticles</p></td><td><p>100â400</p></td><td><p>Feline calicivirus (FCV)</p></td><td><p>ROS generation and subsequent capsid protein oxidation</p></td><td><p>[<xref ref-type="bibr" rid="CR119">119</xref>]</p></td></tr><tr><td><p>Copper iodide (CuI) nanoparticles</p></td><td><p>160</p></td><td><p>Influenza A of swine origin (H1N1)</p></td><td><p>Generation of hydroxyl radicals and degradation of viral proteins</p></td><td><p>[<xref ref-type="bibr" rid="CR120">120</xref>]</p></td></tr></tbody></table></table-wrap></p><p id="Par55">Hepatitis B (HBV) is a viral infection that currently affects 257 million people around the world and was responsible for 887,000 deaths in 2015 according to the World Health Organization [<xref ref-type="bibr" rid="CR121">121</xref>]. Small (10â50ânm) naked silver nanoparticles have been tested as a possible treatment for HBV [<xref ref-type="bibr" rid="CR113">113</xref>] and were shown to bind efficiently to HBV and further inhibit the production of HBV RNA. The mode of action is hypothesized to be due to the AgNPs binding to the HBV dsDNA (double-stranded DNA). Rogers et al. have demonstrated a use for silver nanoparticles, both naked and with a polysaccharide coating as an antiviral agent against monkeypox virus (MPV) [<xref ref-type="bibr" rid="CR114">114</xref>]. The nanoparticles were tested in vitro against MPV at a range of concentrations between 12.5â100âÎ¼g/ml; the results of the study showed that all of the concentrations of polysaccharide-coated silver nanoparticles (Ag-PS-NPs) used were able to reduce MPV-induced plaque formations in vitro.</p><p id="Par56">Silver nanoparticles may even have a role to play in the treatment of human immunodeficiency virus (HIV) [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. HIV is a major health concern, with WHO estimating that 36.7 million people are living with HIV as of 2016 [<xref ref-type="bibr" rid="CR122">122</xref>]. It is important that treatments for HIV are discovered and implemented quickly and efficiently; Lara et al. have demonstrated the effect of silver nanoparticles (30â50ânm) on HIV-1 isolates showing inhibition of all strains of HIV-1 isolates [<xref ref-type="bibr" rid="CR116">116</xref>]. The naked nanoparticles showed an overall IC<sub>50</sub> of 0.44âmg/ml Â±â0.3 against HIV-1, with the mechanism of viral inhibition shown to be the inhibition of virus-host cell binding, specifically the silver nanoparticles inhibit the interaction between the gp120 protein (an envelope glycoprotein) and the target cell membrane receptors. Also demonstrated by the same group was the ability for silver nanoparticles coated with polyvinylpyrrolidone (PVP) to prevent the transfection of HIV-1 into a human cervical tissue explant model [<xref ref-type="bibr" rid="CR115">115</xref>]. Specifically, 0.15âmg/ml PVP-coated silver nanoparticles (PVP-AgNPs) inhibited infection by HIV-<sub>IIIB</sub> and HIV-<sub>AZT-RV</sub> isolates. This concentration of PVP-AgNPs also induced a proliferation of lymphocytes (immune cells) to the site of infection, in comparison to the control sample [<xref ref-type="bibr" rid="CR115">115</xref>].</p><p id="Par57">It is not only silver and coated silver nanoparticles that have been employed against viruses: 2-nm gold nanoparticles coated with an amphiphilic sulfate ligand were also shown to be effective against HIV-1 [<xref ref-type="bibr" rid="CR118">118</xref>]. These particles were shown to target the fusion process of the virus and were shown in vitro to bind to gp120 protein and directly neutralize the HIV-1 infection. Mercaptoethanesulfonate-coated gold nanoparticles (Au-MES) showed an inhibition of herpes simplex virus type 1 (HSV-1) infection, possibly by inhibiting the virus binding to the host cell, cell to cell viral spreading, or alteration of cell susceptibility to viral infection induced by the presence of the nanoparticles [<xref ref-type="bibr" rid="CR117">117</xref>].</p><p id="Par58">Copper-iodide nanoparticles (CuI-NPs) have been shown to have antiviral properties on several different viruses: feline calicivirus (FCV) [<xref ref-type="bibr" rid="CR119">119</xref>] and more interestingly influenza A virus of swine origin (H1N1) [<xref ref-type="bibr" rid="CR120">120</xref>]. One hundred to 400ânm CuI-NPs showed an antiviral property when utilized against FCV, and it was hypothesized that monovalent Cu ions were responsible for the production of a reactive oxygen species (ROS) that caused subsequent capsid protein oxidation, leading to FCV inactivation. H1N1 virus was also shown to be inhibited by CuI-NPs, in a very similar manner, namely the production of hydroxyl radicals, leading to protein degradation. However, these radicals might also prove to be toxic to non-infected tissues, which would be important to determine before a treatment would be approved for use [<xref ref-type="bibr" rid="CR123">123</xref>].</p></sec><sec id="Sec9"><title>Imaging</title><p id="Par59">Magnetic resonance imaging (MRI) scanning is a very useful tool for medical diagnosis and provides clear anatomical images. Using MRI, one can visualize the blood flow, physiochemical traits, and the states of tissues and organs in the body [<xref ref-type="bibr" rid="CR124">124</xref>]. Contrast agents are often employed in MRI for improved diagnostic sensitivity [<xref ref-type="bibr" rid="CR125">125</xref>]. Conventionally used contrast agents are chelate-based, but the major drawbacks of current contrast agents are their biological stability and their toxicity levels when accumulated in cells [<xref ref-type="bibr" rid="CR126">126</xref>]. For example, some contrast agents are iodine-based, and it has been reported that iodinated contrast media exposure is associated with subsequent development of incident hyperthyroidism and incident overt hypothyroidism [<xref ref-type="bibr" rid="CR127">127</xref>]. Alternatives have been developed to provide an improved scanning efficacy by reducing the negative impact contrast agents can have on the body [<xref ref-type="bibr" rid="CR128">128</xref>]. Alternatives include metal nanoparticles possibly conjugated with an agent which acts in a similar manner to a contrast agent for MRI scanning [<xref ref-type="bibr" rid="CR129">129</xref>]. FigureÂ <xref rid="Fig5" ref-type="fig">5</xref> is an MRI contrast image of a rat cerebral cortex pre- and post-treatment of AuNPs [<xref ref-type="bibr" rid="CR130">130</xref>].<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>An MRI contrast image of a rat cerebral cortex pre- (left) and post-treatment (right). The area containing the AuNPs is ringed in red</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/11671_2019_3019_Fig5_HTML.png" id="MO5"/></p></fig></p><p id="Par60">TableÂ <xref rid="Tab3" ref-type="table">3</xref> shows some of the nanoparticles that have been explored for use in medical imaging. Some computed tomography (CT) contrast agents have issues including short circulation half-lives [<xref ref-type="bibr" rid="CR131">131</xref>] and potential tissue damage [<xref ref-type="bibr" rid="CR130">130</xref>]. Due to this, metal nanoparticles have also been investigated for use in CT imaging [<xref ref-type="bibr" rid="CR132">132</xref>]; Au nanoparticles show promising use in imaging due to their X-ray attenuation [<xref ref-type="bibr" rid="CR133">133</xref>]. Kojima et al. showed that gold nanoparticles conjugated with a PEGylated dendrimer (PEG-AuNPs) made for a superior contrast agent in vitro <italic>as well as</italic> for X-ray computed tomography, compared to the commercially available iodine agent iopamidal [<xref ref-type="bibr" rid="CR134">134</xref>]. The PEG-AuNPs showed a higher contrast efficiency than the commercially available iopamidal, with rapid excretion from the body [<xref ref-type="bibr" rid="CR135">135</xref>]. The authors also noted that the PEG-AuNPs had photocytotoxic properties to enable photothermal therapy.<table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Some examples of metal nanoparticles and metal nanoparticle-conjugates that have been investigated for their use in medical imaging</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Type of nanoparticle</p></th><th><p>Size (nm)</p></th><th><p>Scanning type</p></th><th><p>Ref</p></th></tr></thead><tbody><tr><td><p>PEG-AuNPs</p></td><td><p>3â8</p></td><td><p>CT</p></td><td><p>[<xref ref-type="bibr" rid="CR135">135</xref>]</p></td></tr><tr><td><p>Modified AuNPs</p></td><td><p>17â23</p></td><td><p>SPECT/CT</p></td><td><p>[<xref ref-type="bibr" rid="CR136">136</xref>]</p></td></tr><tr><td><p>AuNPs</p></td><td><p>130â147</p></td><td><p>PA</p></td><td><p>[<xref ref-type="bibr" rid="CR137">137</xref>]</p></td></tr><tr><td><p>AuNPs with citraconic amide moieties</p></td><td><p>10</p></td><td><p>PA</p></td><td><p>[<xref ref-type="bibr" rid="CR138">138</xref>]</p></td></tr><tr><td><p>AuNPs in combination with radiotherapy</p></td><td><p>25</p></td><td><p>Dual-energy CT</p></td><td><p>[<xref ref-type="bibr" rid="CR139">139</xref>]</p></td></tr></tbody></table></table-wrap></p><p id="Par61">Li et al. have demonstrated the use of coated AuNPs as an imaging tool for atherosclerosis; the AuNPs were applied in a type of medical imaging called âsingle-photon emission computed tomographyâ (SPECT) [<xref ref-type="bibr" rid="CR136">136</xref>]. This type of imaging is very similar to using a gamma camera, but it is able to provide true 3D images that can be sliced, rotated, and manipulated to achieve a more accurate analytical technique [<xref ref-type="bibr" rid="CR136">136</xref>]. The modified nanoparticles specifically targeted atherosclerosis plaques containing apoptotic macrophages, indicating a useful tool for invasively accurate detection of atherosclerosis plaques [<xref ref-type="bibr" rid="CR136">136</xref>].</p><p id="Par62">AuNPs have previously been demonstrated to be a possible agent for photoacoustic imaging (PA), showing high spatial resolution and sensitivity [<xref ref-type="bibr" rid="CR137">137</xref>]. PA relies on the detection of ultrasonic waves which are emitted from tissues when exposed to non-ionizing pulsed laser irradiation [<xref ref-type="bibr" rid="CR140">140</xref>]. The intensity/magnitude of the ultrasonic emission is responsible for the image contrast, therefore any agent that can both absorb the laser pulses and then give off heat as a result will increase the magnitude of the ultrasonic emission and AuNPs possess the ability to do both of these [<xref ref-type="bibr" rid="CR141">141</xref>, <xref ref-type="bibr" rid="CR142">142</xref>]. AuNPs are potentially better than organic dyes due to the organic dyesâ susceptibility to photo-bleaching and rapid clearing from the blood [<xref ref-type="bibr" rid="CR143">143</xref>]. AuNPs also have use in cell imaging for examining movement of nanoparticles within cells when conjugated with various cargoes. FigureÂ <xref rid="Fig6" ref-type="fig">6</xref> is a darkfield imaging of A431 lung cancer cells treated with AuNPs that target epidermal growth factor receptor, and the bright areas within the cells are the nanoparticles indicating their locations within the cells [<xref ref-type="bibr" rid="CR144">144</xref>].<fig id="Fig6"><label>Fig. 6</label><caption xml:lang="en"><p>Darkfield imaging of A431 lung cancer cells treated with AuNPs; the bright yellow/orange dots are nanoparticles within the cells</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/11671_2019_3019_Fig6_HTML.png" id="MO6"/></p></fig></p></sec><sec id="Sec10"><title>Biomedical Cargo Delivery</title><p id="Par63">Nanoparticles make for an ideal molecule for drug delivery due to the huge surface area to the volume ratio they provide when compared to their bulk material [<xref ref-type="bibr" rid="CR145">145</xref>]. In addition, it is possible to engineer nanoparticles to either avoid or interact with the immune system in specific ways [<xref ref-type="bibr" rid="CR146">146</xref>, <xref ref-type="bibr" rid="CR147">147</xref>]. For example, it has been demonstrated that an increased hydrophobicity of nanoparticles/sub-groups conjugated to the nanoparticles illicit and increased immune response by measuring cytokine mRNA levels in mice [<xref ref-type="bibr" rid="CR146">146</xref>]. Focusing in the opposite direction, it has been suggested that nanoparticles can be conjugated with various ligands to directly activate the immune system to target the destruction of a tumor [<xref ref-type="bibr" rid="CR148">148</xref>] or by accumulation in the liver or spleen for the generation of tolerance or immunity, respectively [<xref ref-type="bibr" rid="CR147">147</xref>].</p><p id="Par64">Gold nanoparticles have been extensively studied for their delivery of medical cargo, for example, Bhumkar et al. have explored the application of AuNPs for trans-mucosal delivery of insulin. Gold nanoparticles were synthesized in the presence of chitosan, which acts as a polymeric stabilizer [<xref ref-type="bibr" rid="CR149">149</xref>]. These nanoparticles were then loaded with insulin and administered both nasally and orally to diabetic rats. The results showed an overall reduction in the ratâs blood glucose levels, an indication of successful movement of the nanoparticles through the mucosal membranes and into the bloodstream.</p><p id="Par65">More recently âsmartâ AuNPs have been employed in PA [<xref ref-type="bibr" rid="CR138">138</xref>]. These nanoparticles are roughly 10ânm in diameter and are functionalized with citraconic amide moieties which are susceptible to hydrolysis. The citraconic amides are converted into positively charged primary amino acids at a mildly acidic pH, while the surface molecules adopt negative charges at physiological pH [<xref ref-type="bibr" rid="CR138">138</xref>]. Combined, these two properties cause the âsmartâ nanoparticles to adopt both positive and negative charges allowing them to aggregate rapidly due to electrostatic attraction. These nanoparticles are referred to as âsmartâ due to the nanoparticles presenting cancer-specific properties and accumulate rapidly and efficiently in cancer tissues and show a much lower accumulation in normal tissues [<xref ref-type="bibr" rid="CR150">150</xref>].</p><p id="Par66">Gold nanoparticles can also be used as a delivery system for nucleic acids [<xref ref-type="bibr" rid="CR153">153</xref>], including oligonucleotides [<xref ref-type="bibr" rid="CR151">151</xref>] and small interfering RNA (siRNA) [<xref ref-type="bibr" rid="CR154">154</xref>]. Many different methods have been developed to functionalize AuNPs with nucleic acids, for example, Yonezawa et al. have synthesized gold nanoparticles modified with thiocholine, which then bound to DNA and formed a fusion of wire-like structures throughout the DNA [<xref ref-type="bibr" rid="CR155">155</xref>]. SandstrÃ¶m et al. demonstrated the ability to bind nucleic acids onto gold nanoparticles [<xref ref-type="bibr" rid="CR151">151</xref>], and a similar modification has been done by Rosi et al. where tetrathiol-modified antisense oligonucleotides were bound to 13-nm gold nanoparticles [<xref ref-type="bibr" rid="CR152">152</xref>]. Being able to conjugate nucleic acids to nanoparticles opens up the possibility of targeted gene delivery, which could, for example, lead to genes coding for a specific protein to be delivered to a cell that was either deficient in that protein or could not produce the protein themselves [<xref ref-type="bibr" rid="CR156">156</xref>]. It has also been exhibited that gold nanoparticles modified with DNA can transfect cancer cells [<xref ref-type="bibr" rid="CR157">157</xref>] (TableÂ <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>A range of nanoparticle conjugates that have been examined for medical delivery of cargos</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Type of Nanoparticle</p></th><th><p>Size (nm)</p></th><th><p>Medical delivery application</p></th><th><p>Ref</p></th></tr></thead><tbody><tr><td><p>Chitosan stabilized AuNPs</p></td><td><p>10â50</p></td><td><p>Delivery of insulin across transmucosal membranes</p></td><td><p>[<xref ref-type="bibr" rid="CR149">149</xref>]</p></td></tr><tr><td><p>AuNPs conjugated to an oligonucleotide modified with thiol groups</p></td><td><p>10â20</p></td><td><p>Delivery of nucleic acids as a potential for gene therapy</p></td><td><p>[<xref ref-type="bibr" rid="CR151">151</xref>]</p></td></tr><tr><td><p>AuNPs conjugated to antisense oligonucleotide modified with tetra-thiol groups</p></td><td><p>13</p></td><td><p>Delivery of nucleic acids as a potential for gene therapy</p></td><td><p>[<xref ref-type="bibr" rid="CR152">152</xref>]</p></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec11"><title>Anticancer Drug Delivery</title><p id="Par67">Cancer is one of the worldâs leading killers with large areas of scientific research being dedicated to the fight against cancer, and nanoparticles offer a new doorway into methods to target and treat cancer. TableÂ <xref rid="Tab5" ref-type="table">5</xref> presents a selection of nanoparticle/drug conjugates that have been tested for anticancer treatments. Paciotti et al. have investigated the application of PEGylated AuNPs as a carrier for tumor necrosis factor (TNF) which is a cell-signaling protein that possess the ability to induce apoptosis in healthy cells [<xref ref-type="bibr" rid="CR158">158</xref>]. The Au-PEG-TNF nanoparticles were injected intravenously and agglomerated significantly more in MC-38 colon carcinoma cells compared to other healthy cells/tissues. The TNF not only gave therapeutic action on the MC-38 cells, but also seemed to possess a targeting property, indicated by the lack of agglomeration in healthy cells. Another interesting observation reported was the ability for the Au-PEG-TNF nanoparticles to diminish a tumor mass compared to âfreeâ TNF.<table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p>A range of nanoparticle conjugates that have been examined for anticancer therapy</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Type of nanoparticle</p></th><th><p>Size (nm)</p></th><th><p>Medical delivery application</p></th><th><p>Ref</p></th></tr></thead><tbody><tr><td><p>PEGylated AuNPs conjugated with TNF</p></td><td><p>30â34</p></td><td><p>Delivery of TNF to cancer cells targeted by the TNF itself, TNF induces cell apoptosis</p></td><td><p>[<xref ref-type="bibr" rid="CR158">158</xref>]</p></td></tr><tr><td><p>AuNPs conjugated with folic acid using a PEG linker</p></td><td><p>10</p></td><td><p>Delivery of folic acid (vitamin B9), a precursor for nucleic acid production</p></td><td><p>[<xref ref-type="bibr" rid="CR159">159</xref>]</p></td></tr><tr><td><p>AuNPs loaded with doxorubicin</p></td><td><p>30â40</p></td><td><p>Delivery of doxorubicin-loaded gold nanoparticles for tumor targeting/therapy</p></td><td><p>[<xref ref-type="bibr" rid="CR160">160</xref>]</p></td></tr><tr><td><p>AuNPs coated with a tumor specific uptake peptide</p></td><td><p>25â40</p></td><td><p>Drug delivery to lymphoma cells with gold nanoparticles conjugated with cellular uptake peptides specific to lymphoma cells</p></td><td><p>[<xref ref-type="bibr" rid="CR161">161</xref>]</p></td></tr></tbody></table></table-wrap></p><p id="Par68">Doxorubicin is a widely used cancer therapeutic agent but has dose-limiting associations with cardiotoxicity. A gold nanoparticle-doxorubicin conjugate has been developed that demonstrates little no to cardiotoxicity to mice while being able to treat cancer [<xref ref-type="bibr" rid="CR160">160</xref>]. Dixit et al. demonstrated the selective delivery of folic acid-coated AuNPs into folate receptor (FR) positive cancer cells, whereas when compared with a cell line that did not have folate receptors, uptake was shown to be minimal [<xref ref-type="bibr" rid="CR159">159</xref>]. These results demonstrated the use of folate to target metal nanoparticles to FR-positive cancer cells for tumor imaging and ablation.</p></sec></sec><sec id="Sec12"><title>Limitations of Single Metal Nanoparticles and Overcoming Them</title><p id="Par69">The principal obstacle with nanoparticle drug delivery is the ability to direct the nanoparticle to the target area [<xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR163">163</xref>]. There are several methods in use for metal nanoparticle targeting such as antibodies [<xref ref-type="bibr" rid="CR164">164</xref>â<xref ref-type="bibr" rid="CR166">166</xref>] and homing peptides [<xref ref-type="bibr" rid="CR167">167</xref>, <xref ref-type="bibr" rid="CR168">168</xref>]. There are however limitations to these methods, with the biggest being that before they even reach the desired target cells they have to pass through a variety of other barriers, such as blood vessels and the blood-brain barrier [<xref ref-type="bibr" rid="CR169">169</xref>]. One way to overcome this targeting limitation is to use magnetic nanoparticles [<xref ref-type="bibr" rid="CR170">170</xref>]. A magnetic nanoparticle-targeting system works by directing the nanoparticles to a target site using an external magnetic field, it has already been demonstrated that the magnetic anisotropy of the nanoparticle is a very important factor for medical treatments [<xref ref-type="bibr" rid="CR171">171</xref>], with a change in anisotropy being able to the change the efficacy of hypothermia treatments for example [<xref ref-type="bibr" rid="CR172">172</xref>]. Superparamagnetic metal nanoparticles have this property (they only present magnetic properties while in the presence of a magnetic field) [<xref ref-type="bibr" rid="CR173">173</xref>]. However, the benefit of magnetic nanoparticles also presents a potential limitation, due to the toxicity of many magnetic materials [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR174">174</xref>, <xref ref-type="bibr" rid="CR175">175</xref>]. Despite iron being approved for various imaging uses [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], it has been suggested in several studies that naked iron oxide nanoparticles may have some adverse effects when used in cell labeling [<xref ref-type="bibr" rid="CR176">176</xref>â<xref ref-type="bibr" rid="CR178">178</xref>]. One method that can be used to overcome any potential toxicity limitations is to coat the iron core [<xref ref-type="bibr" rid="CR179">179</xref>]. A range of materials can be used as the coating material: silica [<xref ref-type="bibr" rid="CR180">180</xref>â<xref ref-type="bibr" rid="CR182">182</xref>], polymers [<xref ref-type="bibr" rid="CR183">183</xref>, <xref ref-type="bibr" rid="CR184">184</xref>], gold [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR185">185</xref>], or silver [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR186">186</xref>]. Gold has low pharmaceutical activity [<xref ref-type="bibr" rid="CR187">187</xref>] and silver has been used in biomedical applications for many years [<xref ref-type="bibr" rid="CR188">188</xref>, <xref ref-type="bibr" rid="CR189">189</xref>],</p><p id="Par70">The combination of a superparamagnetic core with an inert and safe metal coating produces metal nanoparticles with superior characteristics to non-magnetic metal particles [<xref ref-type="bibr" rid="CR190">190</xref>]. As well as reducing toxicity, the coating also provides the potential for the conjugation of functionalized molecules onto the surface, such as drugs and biomolecules for application in the medical field [<xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. It is of note that a core-shell nanoparticle still possesses the properties and uses of a nanoparticle made from the same material as just the shell, but the superparamagnetic core gives the ability to direct the nanoparticle in the body [<xref ref-type="bibr" rid="CR191">191</xref>]. For example, a gold nanoparticle with an antibody is classified as a targeting nanoparticle, introducing the core would classify the nanoparticle as a directed targeting nanoparticle [<xref ref-type="bibr" rid="CR173">173</xref>].</p></sec><sec id="Sec13"><title>Current Medicinal Uses of Gold-Coated Iron Oxide Nanoparticles</title><p id="Par71">Core-shell superparamagnetic nanoparticles have already been assessed for their biomedical uses, with a wide range of uses already being applied [<xref ref-type="bibr" rid="CR192">192</xref>] and with a majority of research investigating into the use of gold as a shell for the nanoparticles, in part due to its biocompatibility and ability to easily bind to a variety of materials. As such, this section will deal exclusively with gold shell nanoparticles. One of these uses is as a magnetic carrier for drug targeting [<xref ref-type="bibr" rid="CR192">192</xref>â<xref ref-type="bibr" rid="CR196">196</xref>]. Kayal and Ramanujan have tested an in vitro apparatus that simulates the human circulatory system as a test for the magnetic delivery of gold-coated iron oxide nanoparticles (Au-Fe<sub>3</sub>O<sub>4</sub>) loaded with doxorubicin [<xref ref-type="bibr" rid="CR194">194</xref>]. Their system had various magnetic fields of increasing strength next to a capillary through which the doxorubicin-loaded particles were passed. A significant percentage of these nanoparticles were captured within the magnetic fields, strongly indicating the potential for the use of magnetic nanoparticles in drug delivery. Another use for a targeted system is the application of Au-Fe<sub>3</sub>O<sub>4</sub> nanoparticles in photothermal therapy. Bhana et al. demonstrated the use of a core-shell system used in combination therapy deployed against two different cancer cell lines; head and neck (KB-3-1) and breast (SK-BR-3) with a reported decrease in cell viability of 64% when they exposed cell lines to a combined photothermal and photodynamic therapy, compared to each modality used on its own [<xref ref-type="bibr" rid="CR197">197</xref>]. In photothermal therapy, gold nanoparticles are coated with a ligand, such as PEG [<xref ref-type="bibr" rid="CR142">142</xref>], and these nanoparticles are irradiated with a laser, with a wavelength that matches the UV-vis <italic>Î»</italic>-max of the gold nanoparticles [<xref ref-type="bibr" rid="CR194">194</xref>]. The nanoparticles vibrate at the laserâs frequency which causes heat to be released causing the death of the surrounding tissue [<xref ref-type="bibr" rid="CR198">198</xref>], introducing a core which is superparamagnetic can allow for a more accurate targeting for use in this therapy. Similarly, it has been reported by Kirui et al. that gold hybrid nanoparticles were deployed against SW1222 colorectal cancer in photothermal therapy, showing an increased case of cellular apoptosis after therapy, with their conclusion being that the cells showed an increased uptake, leading to a reduced laser power required to reach threshold therapeutic levels [<xref ref-type="bibr" rid="CR199">199</xref>]<italic>.</italic> The use of core-shell nanoparticles for photothermal therapy of cancer has also been reported by other groups [<xref ref-type="bibr" rid="CR200">200</xref>, <xref ref-type="bibr" rid="CR201">201</xref>].</p><p id="Par72">Metal nanoparticles have already shown to have a place in contrast imaging, for example core-shell nanoparticles can also be used in T<sub>1-</sub> and T<sub>2</sub>-weighted imaging in MRI [<xref ref-type="bibr" rid="CR202">202</xref>]. Research by Cho et al. demonstrated that gold-coated iron nanoparticles can be successfully used in MRI imaging, as well as opening the route for conjugating various ligands for use in biosensors [<xref ref-type="bibr" rid="CR202">202</xref>]<italic>.</italic> A magnetic carrier capable of imaging and photothermal therapy has been reported by Cheng et al. They demonstrated the magnetic targeting of multi-functional nanoparticles to a tumor in a mouse model, which could be imaged inside the tumor and showed a reduction in the tumor size when combined with photothermal therapy [<xref ref-type="bibr" rid="CR203">203</xref>]<italic>.</italic> It is also of note that in this work, both the nanoparticle dosage (1.6âmg/kg) and laser power (1âW/cm<sup>2</sup>) are among the lowest applied for in vivo photothermal therapy. Moreover, there was no obvious toxicity from the nanoparticles reported. TableÂ <xref rid="Tab6" ref-type="table">6</xref> presents some of the currently reported uses of core-shell nanoparticles.<table-wrap id="Tab6"><label>Table 6</label><caption xml:lang="en"><p>Examples of the medical uses already been demonstrated for gold-coated iron magnetic nanoparticles</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Type of nanoparticle</p></th><th><p>Medical application</p></th><th><p>Ref</p></th></tr></thead><tbody><tr><td><p>Gold-coated iron oxide</p></td><td><p>Targeted delivery of doxorubicin</p></td><td><p>[<xref ref-type="bibr" rid="CR194">194</xref>]</p></td></tr><tr><td><p>Gold-coated iron oxide</p></td><td><p>Photothermal and photodynamic combination anticancer treatment</p></td><td><p>[<xref ref-type="bibr" rid="CR197">197</xref>]</p></td></tr><tr><td><p>Gold hybrid nanoparticles</p></td><td><p>Photothermal anticancer therapy</p></td><td><p>[<xref ref-type="bibr" rid="CR199">199</xref>]</p></td></tr><tr><td><p>Gold-coated iron nanoparticles</p></td><td><p>T<sub>1</sub>- and T<sub>2</sub>-MRI imaging</p></td><td><p>[<xref ref-type="bibr" rid="CR202">202</xref>]</p></td></tr><tr><td><p>Multifunctional gold nanoparticle</p></td><td><p>Magnetically directed tumor targeting in mice for phototherapy and imaging of the particles</p></td><td><p>[<xref ref-type="bibr" rid="CR203">203</xref>]</p></td></tr><tr><td><p>Multifunctional gold-coated iron oxide</p></td><td><p>Cancer diagnosis and therapy</p></td><td><p>[<xref ref-type="bibr" rid="CR204">204</xref>]</p></td></tr><tr><td><p>Gold-coated iron oxide</p></td><td><p>Cancer therapy</p></td><td><p>[<xref ref-type="bibr" rid="CR205">205</xref>]</p></td></tr><tr><td><p>Gold-coated iron oxide</p></td><td><p>MRI/PA imaging</p></td><td><p>[<xref ref-type="bibr" rid="CR206">206</xref>]</p></td></tr></tbody></table></table-wrap></p><p id="Par73">Another medical area where such core-shell metal nanoparticles have been suggested to make an impact is in directed enzyme prodrug therapy (DEPT) [<xref ref-type="bibr" rid="CR170">170</xref>, <xref ref-type="bibr" rid="CR191">191</xref>]. DEPT is a promising method of cancer treatment, with several therapies making it through to clinical trials [<xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR208">208</xref>]. The main principal of DEPT is the targeted delivery of a prodrug-activating enzyme to a tumor site. Upon arrival at the tumor site, the enzyme enters the target cells where it can later activate an administered prodrug. However, the efficacy of the therapy depends on the ability to direct the enzyme to the tumor site, with current directional techniques relying on passive targeting methods such as viruses [<xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR209">209</xref>] or antibodies [<xref ref-type="bibr" rid="CR210">210</xref>, <xref ref-type="bibr" rid="CR211">211</xref>], rather than an active targeting system for enzyme delivery. A novel therapy proposed by Gwenin et al. potentially overcomes the targeting issue [<xref ref-type="bibr" rid="CR170">170</xref>, <xref ref-type="bibr" rid="CR212">212</xref>]. This approach involves conjugating a genetically modified prodrug-activating enzyme onto the surface of a gold-coated iron oxide superparamagnetic nanoparticle (AuMNP), then directing the AuMNP-enzyme conjugate to the target site using a magnetic field to increase the efficacy of the targeted therapy. FigureÂ <xref rid="Fig7" ref-type="fig">7</xref> presents some of the uses of a core-shell nanoparticle.<fig id="Fig7"><label>Fig. 7</label><caption xml:lang="en"><p>A pictorial representation of the applications of core/shell nanoparticles</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/11671_2019_3019_Fig7_HTML.png" id="MO7"/></p></fig></p></sec><sec id="Sec14" sec-type="conclusions"><title>Conclusions</title><p id="Par74">In brief, single metal nanoparticles have been shown to currently possess a wide range of biomedical applications, with more application for these nanoparticles being discovered. One of the limiting factors that these nanoparticles face in medical treatments is to find a way for precise accurate targeting of areas within the body, be it for targeting of a drug delivery or for therapies involving the nanoparticles directly. A way to overcome this is to employ a magnetic core to create core-shell nanoparticles that can then be directed around a body using a magnetic field. There are a variety of methods that can be used to synthesize these core-shell nanoparticles, with each method having its own advantages and disadvantages. There remain many obstacles for core-shell nanoparticles before they can be routinely applied in the medical field and these include<list list-type="order"><list-item><p id="Par75">Achieving a synthesis route which produces easily repeatable results;</p></list-item><list-item><p id="Par76">Producing particles of a set size [<xref ref-type="bibr" rid="CR22">22</xref>â<xref ref-type="bibr" rid="CR24">24</xref>] and shape [<xref ref-type="bibr" rid="CR25">25</xref>â<xref ref-type="bibr" rid="CR28">28</xref>]; and</p></list-item><list-item><p id="Par77">Producing large enough quantities to make it economically viable [<xref ref-type="bibr" rid="CR29">29</xref>].</p></list-item></list></p><p id="Par78">Another key factor is the relatively unknown toxicity of some nanoparticles over an extended period of time due to how relatively new the field of research is.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable</p></ack><sec sec-type="author-contribution"><title>Authorsâ Contributions</title><p>SDA coordinated the content, compilation, and writing of all sections, VVG proofed the paper and guided the content, tables and text. CDG coordinated the editing of all sections and final editing of the paper. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>The authors thank the School of Chemistry at Bangor University for their support throughout this project, as well as funding from Welsh Government, the Life Sciences Research Network Wales, Cancer Research Wales and the Knowledge Economy Skills Scholarship (KESS).</p></sec><sec sec-type="data-availability"><title>Availability of Data and Materials</title><p>Not applicable</p></sec><sec sec-type="ethics-statement"><sec id="FPar1" sec-type="COI-statement"><title>Competing Interests</title><p id="Par79">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann-Amtenbrink</surname><given-names>M</given-names></name><name><surname>Grainger</surname><given-names>DW</given-names></name><name><surname>Hofmann</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Nanoparticles in medicine: current challenges facing inorganic nanoparticle toxicity assessments and standardizations</article-title><source>Nanomedicine</source><year>2015</year><volume>11</volume><fpage>1689</fpage><lpage>1694</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhtVWqs7%2FO</pub-id><pub-id pub-id-type="doi">10.1016/j.nano.2015.05.005</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Levenson</surname><given-names>RM</given-names></name><etal/></person-group><article-title xml:lang="en">In vivo cancer targeting and imaging with semiconductor quantum dots</article-title><source>Nat Biotechnol</source><year>2004</year><volume>22</volume><fpage>969</fpage><lpage>976</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXmtFWru74%3D</pub-id><pub-id pub-id-type="doi">10.1038/nbt994</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akerman</surname><given-names>ME</given-names></name><name><surname>Chan</surname><given-names>WCW</given-names></name><name><surname>Laakkonen</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Nanocrystal targeting in vivo</article-title><source>Proc Natl Acad Sci</source><year>2002</year><volume>99</volume><fpage>12617</fpage><lpage>12621</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XnvFGiu7c%3D</pub-id><pub-id pub-id-type="doi">10.1073/pnas.152463399</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>YT</given-names></name><name><surname>Soltesz</surname><given-names>EG</given-names></name><etal/></person-group><article-title xml:lang="en">Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping</article-title><source>Nat Biotechnol</source><year>2004</year><volume>22</volume><fpage>93</fpage><lpage>97</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXls1ej</pub-id><pub-id pub-id-type="doi">10.1038/nbt920</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harisinghani</surname><given-names>MG</given-names></name><name><surname>Barentsz</surname><given-names>J</given-names></name><name><surname>Hahn</surname><given-names>PF</given-names></name><etal/></person-group><article-title xml:lang="en">Noninvasive detection of clinically occult lymph-node metastases in prostate cancer</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>2491</fpage><lpage>2499</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa022749</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>Y-M</given-names></name><name><surname>Jun</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>H-T</given-names></name><etal/></person-group><article-title xml:lang="en">In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals</article-title><source>J Am Chem Soc</source><year>2005</year><volume>127</volume><fpage>12387</fpage><lpage>12391</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXnslOrtbw%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja052337c</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">The dawning era of polymer therapeutics</article-title><source>Nat Rev Drug Discov</source><year>2003</year><volume>2</volume><fpage>347</fpage><lpage>360</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXjslamtb0%3D</pub-id><pub-id pub-id-type="doi">10.1038/nrd1088</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>TM</given-names></name><name><surname>Cullis</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Drug delivery systems: entering the mainstream</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1818</fpage><lpage>1822</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXitFehu70%3D</pub-id><pub-id pub-id-type="doi">10.1126/science.1095833</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micha</surname><given-names>JP</given-names></name><name><surname>Goldstein</surname><given-names>BH</given-names></name><name><surname>Birk</surname><given-names>CL</given-names></name><etal/></person-group><article-title xml:lang="en">Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions</article-title><source>Gynecol Oncol</source><year>2006</year><volume>100</volume><fpage>437</fpage><lpage>438</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XjsFOjsw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ygyno.2005.09.012</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Eavarone</surname><given-names>D</given-names></name><name><surname>Capila</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="en">Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system</article-title><source>Nature</source><year>2005</year><volume>436</volume><fpage>568</fpage><lpage>572</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXmsFCgs70%3D</pub-id><pub-id pub-id-type="doi">10.1038/nature03794</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Garcia</surname><given-names>E</given-names></name><name><surname>Andrieux</surname><given-names>K</given-names></name><name><surname>Gil</surname><given-names>S</given-names></name><name><surname>Couvreur</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?</article-title><source>Int J Pharm</source><year>2005</year><volume>298</volume><fpage>274</fpage><lpage>292</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXlvV2nurs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ijpharm.2005.03.031</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlachetzki</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Boado</surname><given-names>RJ</given-names></name><name><surname>Pardridge</surname><given-names>WM</given-names></name></person-group><article-title xml:lang="en">Gene therapy of the brain: the trans-vascular approach</article-title><source>Neurology</source><year>2004</year><volume>62</volume><fpage>1275</fpage><lpage>1281</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXivV2jsLY%3D</pub-id><pub-id pub-id-type="doi">10.1212/01.WNL.0000120551.38463.D9</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popovic</surname><given-names>N</given-names></name><name><surname>Brundin</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases</article-title><source>Int J Pharm</source><year>2006</year><volume>314</volume><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xktlejsbw%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ijpharm.2005.09.040</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olbrich</surname><given-names>C</given-names></name><name><surname>Bakowsky</surname><given-names>U</given-names></name><name><surname>Lehr</surname><given-names>CM</given-names></name><etal/></person-group><article-title xml:lang="en">Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA</article-title><source>J Control Release</source><year>2001</year><volume>77</volume><fpage>345</fpage><lpage>355</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXoslGntLc%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0168-3659(01)00506-5</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabatt</surname><given-names>K</given-names></name><name><surname>Sameti</surname><given-names>M</given-names></name><name><surname>Olbrich</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer</article-title><source>Eur J Pharm Biopharm</source><year>2004</year><volume>57</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXhslWltLY%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ejpb.2003.10.015</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jaeghere</surname><given-names>F</given-names></name><name><surname>AllÃ©mann</surname><given-names>E</given-names></name><name><surname>Kubel</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state</article-title><source>J Control Release</source><year>2000</year><volume>68</volume><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/S0168-3659(00)00272-8</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignatello</surname><given-names>R</given-names></name><name><surname>Bucolo</surname><given-names>C</given-names></name><name><surname>Spedalieri</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application</article-title><source>Biomaterials</source><year>2002</year><volume>23</volume><fpage>3247</fpage><lpage>3255</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XjvVGisb8%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0142-9612(02)00080-7</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignatello</surname><given-names>R</given-names></name><name><surname>Bucolo</surname><given-names>C</given-names></name><name><surname>Ferrara</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Eudragit RS100<bold>Â®</bold> nanosuspensions for the ophthalmic controlled delivery of ibuprofen</article-title><source>Eur J Pharm Sci</source><year>2002</year><volume>16</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XltFWitL0%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0928-0987(02)00057-X</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">The use of mucoadhesive polymers in ocular drug delivery</article-title><source>Adv Drug Deliv Rev</source><year>2005</year><volume>57</volume><fpage>1595</fpage><lpage>1639</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtFSis7fF</pub-id><pub-id pub-id-type="doi">10.1016/j.addr.2005.07.005</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>JOHN</surname><given-names>ALISON E.</given-names></name><name><surname>LUKACS</surname><given-names>NICHOLAS W.</given-names></name><name><surname>BERLIN</surname><given-names>AARON A.</given-names></name><name><surname>PALECANDA</surname><given-names>AIYAPPA</given-names></name><name><surname>BARGATZE</surname><given-names>ROBERT F.</given-names></name><name><surname>STOOLMAN</surname><given-names>LLOYD M.</given-names></name><name><surname>NAGY</surname><given-names>JON O.</given-names></name></person-group><article-title xml:lang="en">Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease</article-title><source>The FASEB Journal</source><year>2003</year><volume>17</volume><issue>15</issue><fpage>2296</fpage><lpage>2298</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXpvVSnurk%3D</pub-id><pub-id pub-id-type="doi">10.1096/fj.03-0166fje</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Kumar M, Xiaoyuan K, Behera AK et al (2003) Chitosan IFN-Î³-pDNA nanoparticle (CIN) therapy for allergic asthma. Genet Vaccines Ther 1:1-10</mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teranishi</surname><given-names>T</given-names></name><name><surname>Miyake</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Size control of palladium nanoparticles and their crystal structures</article-title><source>Chem Mater</source><year>1998</year><volume>10</volume><fpage>594</fpage><lpage>600</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXms1Ghtg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1021/cm9705808</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Size-controlled synthesis of magnetite nanoparticles</article-title><source>J Am Chem Soc</source><year>2002</year><volume>124</volume><fpage>8204</fpage><lpage>8205</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38Xks1arurY%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja026501x</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pileni</surname><given-names>M-P</given-names></name></person-group><article-title xml:lang="en">The role of soft colloidal templates in controlling the size and shape of inorganic nanocrystals</article-title><source>Nat Mater</source><year>2003</year><volume>2</volume><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXhsFGhtL4%3D</pub-id><pub-id pub-id-type="doi">10.1038/nmat817</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Shape-controlled synthesis of gold and silver nanoparticles</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>2176</fpage><lpage>2179</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XpsVSkt7Y%3D</pub-id><pub-id pub-id-type="doi">10.1126/science.1077229</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manna</surname><given-names>L</given-names></name><name><surname>Scher</surname><given-names>EC</given-names></name><name><surname>Alivisatos</surname><given-names>AP</given-names></name></person-group><article-title xml:lang="en">Synthesis of soluble and processable rod-, arrow-, teardrop-, and tetrapod-shaped CdSe nanocrystals</article-title><source>J Am Chem Soc</source><year>2000</year><volume>122</volume><fpage>12700</fpage><lpage>12706</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3cXotl2nt78%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja003055+</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadogbe</surname><given-names>M</given-names></name><name><surname>Ansar</surname><given-names>SM</given-names></name><name><surname>Chu</surname><given-names>IW</given-names></name><etal/></person-group><article-title xml:lang="en">Comparative study of the self-assembly of gold and silver nanoparticles onto thiophene oil</article-title><source>Langmuir</source><year>2014</year><volume>30</volume><fpage>11520</fpage><lpage>11527</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhsFSqur%2FF</pub-id><pub-id pub-id-type="doi">10.1021/la502574p</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klajn</surname><given-names>R</given-names></name><name><surname>Pinchuk</surname><given-names>AO</given-names></name><name><surname>Schatz</surname><given-names>GC</given-names></name><name><surname>Grzybowski</surname><given-names>BA</given-names></name></person-group><article-title xml:lang="en">Synthesis of heterodimeric sphere-prism nanostructures via metastable gold supraspheres</article-title><source>Angew Chem Int Ed</source><year>2007</year><volume>46</volume><fpage>8363</fpage><lpage>8367</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtlyjsrrJ</pub-id><pub-id pub-id-type="doi">10.1002/anie.200702570</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Warren</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis, characterization, and application of novel polymeric nanoparticles</article-title><source>Macromolecules</source><year>2007</year><volume>40</volume><fpage>499</fpage><lpage>508</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXjtVemuw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1021/ma0613739</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzola</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Commercializing nanotechnology</article-title><source>Nat Biotechnol</source><year>2003</year><volume>21</volume><fpage>1137</fpage><lpage>1143</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXns1Cls7Y%3D</pub-id><pub-id pub-id-type="doi">10.1038/nbt1003-1137</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markides</surname><given-names>H</given-names></name><name><surname>Rotherham</surname><given-names>M</given-names></name><name><surname>El Haj</surname><given-names>AJ</given-names></name></person-group><article-title xml:lang="en">Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine</article-title><source>J Nanomater</source><year>2012</year><volume>2012</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1155/2012/614094</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtlWku77I</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Buzea C, Pacheco I (2019) Toxicity of nanoparticles. In: Nanotechnology in eco-efficient construction. Elsevier, pp 705â754</mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faraji</surname><given-names>AH</given-names></name><name><surname>Wipf</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Nanoparticles in cellular drug delivery</article-title><source>Bioorganic Med Chem</source><year>2009</year><volume>17</volume><fpage>2950</fpage><lpage>2962</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXksVWlur0%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bmc.2009.02.043</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Nehl</surname><given-names>CL</given-names></name><name><surname>Hafner</surname><given-names>JH</given-names></name></person-group><article-title xml:lang="en">Biomedical applications of plasmon resonant metal nanoparticles</article-title><source>Nanomedicine (Lond)</source><year>2006</year><volume>1</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XpsFKisLw%3D</pub-id><pub-id pub-id-type="doi">10.2217/17435889.1.2.201</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanone</surname><given-names>S</given-names></name><name><surname>Boczkowski</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Biomedical applications and potential health risks of nanomaterials: molecular mechanisms</article-title><source>Curr Mol Med</source><year>2006</year><volume>6</volume><fpage>651</fpage><lpage>663</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XosVeksbo%3D</pub-id><pub-id pub-id-type="doi">10.2174/156652406778195026</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>LJ</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Nanoparticle-based targeted drug delivery</article-title><source>Exp Mol Pathol</source><year>2009</year><volume>86</volume><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXlslWhtrs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.yexmp.2008.12.004</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruis</surname><given-names>FE</given-names></name><name><surname>Fissan</surname><given-names>H</given-names></name><name><surname>Peled</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Synthesis of nanoparticles in the gas phase for electronic, optical and magnetic applicationsâa review</article-title><source>J Aerosol Sci</source><year>1998</year><volume>29</volume><fpage>511</fpage><lpage>535</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXjslygtLk%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0021-8502(97)10032-5</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Yamamuro</surname><given-names>S</given-names></name><name><surname>Farrell</surname><given-names>D</given-names></name><name><surname>Majetich</surname><given-names>SA</given-names></name></person-group><article-title xml:lang="en">Gold-coated iron nanoparticles for biomedical applications</article-title><source>J Appl Phys</source><year>2003</year><volume>93</volume><fpage>7551</fpage><lpage>7553</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXjslSnsL0%3D</pub-id><pub-id pub-id-type="doi">10.1063/1.1555312</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>PC</given-names></name><name><surname>Turkevich</surname><given-names>J</given-names></name><name><surname>Hillier</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">A study of the nucleation and growth processes in the synthesis of</article-title><source>Discuss Faraday Soc</source><year>1951</year><volume>11</volume><fpage>55</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1039/df9511100055</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuenya</surname><given-names>BR</given-names></name></person-group><article-title xml:lang="en">Synthesis and catalytic properties of metal nanoparticles: size, shape, support, composition, and oxidation state effects</article-title><source>Thin Solid Films</source><year>2010</year><volume>518</volume><fpage>3127</fpage><lpage>3150</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXjtFGksb8%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.tsf.2010.01.018</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurent</surname><given-names>S</given-names></name><name><surname>Forge</surname><given-names>D</given-names></name><name><surname>Port</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications</article-title><source>Chem Rev</source><year>2008</year><volume>108</volume><fpage>2064</fpage><lpage>2110</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXmvFCjtb0%3D</pub-id><pub-id pub-id-type="doi">10.1021/cr068445e</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>D</given-names></name><name><surname>Hyeon</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Chemical design of biocompatible iron oxide nanoparticles for medical applications</article-title><source>Small</source><year>2013</year><volume>9</volume><fpage>1450</fpage><lpage>1466</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhvVWgur7P</pub-id><pub-id pub-id-type="doi">10.1002/smll.201202111</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eastoe</surname><given-names>J</given-names></name><name><surname>Hollamby</surname><given-names>MJ</given-names></name><name><surname>Hudson</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Recent advances in nanoparticle synthesis with reversed micelles</article-title><source>Adv Colloid Interf Sci</source><year>2006</year><volume>128â130</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.cis.2006.11.009</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhsFCrs7c%3D</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraes Silva</surname><given-names>S</given-names></name><name><surname>Tavallaie</surname><given-names>R</given-names></name><name><surname>Sandiford</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Gold coated magnetic nanoparticles: from preparation to surface modification for analytical and biomedical applications</article-title><source>Chem Commun</source><year>2016</year><volume>52</volume><fpage>7528</fpage><lpage>7540</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xns1egurw%3D</pub-id><pub-id pub-id-type="doi">10.1039/C6CC03225G</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>C-L</given-names></name><name><surname>Qian</surname><given-names>K</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Monodisperse Î±-Fe2O3@ SiO 2@ Au core/shell nanocomposite spheres: synthesis, characterization and properties</article-title><source>Nanotechnology</source><year>2008</year><volume>19</volume><fpage>125601</fpage><pub-id pub-id-type="doi">10.1088/0957-4484/19/12/125601</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXmvVSgsrc%3D</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesias-Silva</surname><given-names>E</given-names></name><name><surname>Vilas-Vilela</surname><given-names>JL</given-names></name><name><surname>LÃ³pez-Quintela</surname><given-names>MA</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis of gold-coated iron oxide nanoparticles</article-title><source>J Non-Cryst Solids</source><year>2010</year><volume>356</volume><fpage>1233</fpage><lpage>1235</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXntVCru7o%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.jnoncrysol.2010.04.022</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutonnet</surname><given-names>M</given-names></name><name><surname>Kizling</surname><given-names>J</given-names></name><name><surname>Stenius</surname><given-names>P</given-names></name><name><surname>Maire</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">The preparation of monodisperse colloidal metal particles from microemulsions</article-title><source>Colloids Surf</source><year>1982</year><volume>5</volume><fpage>209</fpage><lpage>225</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL38Xmt1eltbg%3D</pub-id><pub-id pub-id-type="doi">10.1016/0166-6622(82)80079-6</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanford</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Theory of micelle formation in aqueous solutions</article-title><source>J Phys Chem</source><year>1974</year><volume>78</volume><fpage>2469</fpage><lpage>2479</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaE2MXkvVGhtb4%3D</pub-id><pub-id pub-id-type="doi">10.1021/j100617a012</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pileni</surname><given-names>MP</given-names></name></person-group><article-title xml:lang="en">Nanosized particles made in colloidal assemblies</article-title><source>Langmuir</source><year>1997</year><volume>13</volume><fpage>3266</fpage><lpage>3276</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2sXjslais74%3D</pub-id><pub-id pub-id-type="doi">10.1021/la960319q</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>JD</given-names></name><name><surname>P A</surname><given-names>B</given-names></name><name><surname>B A</surname><given-names>K</given-names></name><name><surname>Johnston</surname><given-names>KP</given-names></name></person-group><article-title xml:lang="en">Synthesis of cadmium sulfide Q particles in water-in-CO 2 microemulsions</article-title><source>Langmuir</source><year>1999</year><volume>15</volume><fpage>6613</fpage><lpage>6615</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXlsFSrt70%3D</pub-id><pub-id pub-id-type="doi">10.1021/la990510a</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohde</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>X-R</given-names></name><name><surname>Wai</surname><given-names>CM</given-names></name><name><surname>Rodriguez</surname><given-names>JM</given-names></name></person-group><article-title xml:lang="en">Synthesizing silver halide nanoparticles in supercritical carbon dioxide utilizing a water-in-CO2 microemulsion</article-title><source>Chem Commun</source><year>2000</year><volume>2354</volume><fpage>2353</fpage><lpage>2354</lpage><pub-id pub-id-type="doi">10.1039/b005924m</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohde</surname><given-names>H</given-names></name><name><surname>Wai</surname><given-names>CM</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Hydrogenation of olefins in supercritical CO 2 catalyzed by palladium nanoparticles in a water-in-CO 2 microemulsion</article-title><source>J Am Chem Soc</source><year>2002</year><volume>124</volume><fpage>4540</fpage><lpage>4541</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XisFSgt78%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja012232j</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>EE</given-names></name><name><surname>Seip</surname><given-names>CT</given-names></name><name><surname>OâConnor</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Magnetism of nanophase metal and metal alloy particles formed in ordered phases</article-title><source>J Appl Phys</source><year>1999</year><volume>85</volume><fpage>5184</fpage><lpage>5186</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXis1ekur0%3D</pub-id><pub-id pub-id-type="doi">10.1063/1.369118</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>KT</given-names></name><name><surname>Hwang</surname><given-names>HS</given-names></name><name><surname>Ryoo</surname><given-names>W</given-names></name><name><surname>Johnston</surname><given-names>KP</given-names></name></person-group><article-title xml:lang="en">Synthesis of TiO2 nanoparticles utilizing hydrated reverse micelles in CO2</article-title><source>Langmuir</source><year>2004</year><volume>20</volume><fpage>2466</fpage><lpage>2471</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXht1GisLg%3D</pub-id><pub-id pub-id-type="doi">10.1021/la035646u</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bommarius</surname><given-names>AS</given-names></name><name><surname>Holzwarth</surname><given-names>JF</given-names></name><name><surname>Wang</surname><given-names>DIC</given-names></name><name><surname>Hatton</surname><given-names>TA</given-names></name></person-group><article-title xml:lang="en">Coalescence and solubilizate exchange in a cationic four-component reversed micellar system</article-title><source>J Phys Chem</source><year>1990</year><volume>94</volume><fpage>7232</fpage><lpage>7239</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK3cXlt1Wgs7k%3D</pub-id><pub-id pub-id-type="doi">10.1021/j100381a051</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Raveendran</surname><given-names>P</given-names></name><name><surname>Shervani</surname><given-names>Z</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis of Ag and AgI quantum dots in AOT-stabilized water-in-CO 2 microemulsions</article-title><source>Chem A Eur J</source><year>2005</year><volume>11</volume><fpage>1854</fpage><lpage>1860</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXisVWju7w%3D</pub-id><pub-id pub-id-type="doi">10.1002/chem.200400508</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ikushima</surname><given-names>Y</given-names></name><name><surname>Shervani</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Environmentally benign preparation of metal nano-particles by using water-in-CO2 microemulsions technology</article-title><source>Curr Opin Solid State Mater Sci</source><year>2003</year><volume>7</volume><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXptVSntrc%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cossms.2003.09.005</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesias-Silva</surname><given-names>E</given-names></name><name><surname>Rivas</surname><given-names>J</given-names></name><name><surname>LeÃ³n Isidro</surname><given-names>LM</given-names></name><name><surname>LÃ³pez-Quintela</surname><given-names>MA</given-names></name></person-group><article-title xml:lang="en">Synthesis of silver-coated magnetite nanoparticles</article-title><source>J Non-Cryst Solids</source><year>2007</year><volume>353</volume><fpage>829</fpage><lpage>831</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXjtFKhs7s%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.jnoncrysol.2006.12.050</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>EE</given-names></name><name><surname>Sangregorio</surname><given-names>C</given-names></name><name><surname>Connor</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Effects of shell thickness on blocking temperature of nanocomposites of metal particles with gold shells</article-title><source>IEEE Trans Magn</source><year>1999</year><volume>35</volume><fpage>3496</fpage><lpage>3498</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXnt1Srsb0%3D</pub-id><pub-id pub-id-type="doi">10.1109/20.800568</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Kumbhar</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Gold-coated Iron (Fe@ Au) nanoparticles: synthesis, characterization, and magnetic field-induced self-assembly</article-title><source>J Solid State Chem</source><year>2001</year><volume>159</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXks1Wktr8%3D</pub-id><pub-id pub-id-type="doi">10.1006/jssc.2001.9117</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S-J</given-names></name><name><surname>Idrobo</surname><given-names>J-C</given-names></name><name><surname>Olamit</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Growth mechanisms and oxidation resistance of gold-coated iron nanoparticles</article-title><source>Chem Mater</source><year>2005</year><volume>17</volume><fpage>3181</fpage><lpage>3186</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXjvFyktL0%3D</pub-id><pub-id pub-id-type="doi">10.1021/cm0500713</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamer</surname><given-names>U</given-names></name><name><surname>Cetin</surname><given-names>D</given-names></name><name><surname>Suludere</surname><given-names>Z</given-names></name><etal/></person-group><article-title xml:lang="en">Gold-coated iron composite nanospheres targeted the detection of Escherichia coli</article-title><source>Int J Mol Sci</source><year>2013</year><volume>14</volume><fpage>6223</fpage><lpage>6240</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXlt1GjurY%3D</pub-id><pub-id pub-id-type="doi">10.3390/ijms14036223</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pana</surname><given-names>O</given-names></name><name><surname>Teodorescu</surname><given-names>CM</given-names></name><name><surname>Chauvet</surname><given-names>O</given-names></name><etal/></person-group><article-title xml:lang="en">Structure, morphology and magnetic properties of Fe-Au core-shell nanoparticles</article-title><source>Surf Sci</source><year>2007</year><volume>601</volume><fpage>4352</fpage><lpage>4357</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtVOrt73O</pub-id><pub-id pub-id-type="doi">10.1016/j.susc.2007.06.024</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seip</surname><given-names>CT</given-names></name><name><surname>OâConnor</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Fabrication and organization of self-assembled metallic nanoparticles formed in reverse micelles</article-title><source>Nanostruct Mater</source><year>1999</year><volume>12</volume><fpage>183</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/S0965-9773(99)00094-X</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez Perez</surname><given-names>JA</given-names></name><name><surname>Lopez Quintela</surname><given-names>MA</given-names></name><name><surname>Mira</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Advances in the preparation of magnetic nanoparticles by the microemulsion method</article-title><source>J Phys Chem B</source><year>1997</year><volume>101</volume><fpage>8045</fpage><lpage>8047</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2sXmtFCks7o%3D</pub-id><pub-id pub-id-type="doi">10.1021/jp972046t</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Post</surname><given-names>M</given-names></name><name><surname>Veres</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Laser-assisted synthesis of superparamagnetic Fe@ Au core-shell nanoparticles</article-title><source>J Phys Chem B</source><year>2006</year><volume>110</volume><fpage>7122</fpage><lpage>7128</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xis1Ontbo%3D</pub-id><pub-id pub-id-type="doi">10.1021/jp0560967</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takami</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Mousavand</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Hydrothermal synthesis of surface-modified iron oxide nanoparticles</article-title><source>Mater Lett</source><year>2007</year><volume>61</volume><fpage>4769</fpage><lpage>4772</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtVWqt73F</pub-id><pub-id pub-id-type="doi">10.1016/j.matlet.2007.03.024</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H-Y</given-names></name><name><surname>Schadt</surname><given-names>MJ</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Fabrication of magnetic core@ shell Fe oxide@ Au nanoparticles for interfacial bioactivity and bio-separation</article-title><source>Langmuir</source><year>2007</year><volume>23</volume><fpage>9050</fpage><lpage>9056</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXns1Cms7c%3D</pub-id><pub-id pub-id-type="doi">10.1021/la701305f</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>HL</given-names></name><name><surname>Hou</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>WX</given-names></name><name><surname>Wu</surname><given-names>JH</given-names></name></person-group><article-title xml:lang="en">Synthesis of monosized core-shell Fe3O4/Au multifunctional nanoparticles by PVP-assisted nanoemulsion process</article-title><source>Colloids Surfaces A Physicochem Eng Asp</source><year>2010</year><volume>356</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhs1WitLY%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.colsurfa.2009.12.023</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Raja</surname><given-names>S. O.</given-names></name><name><surname>Sardar</surname><given-names>M.</given-names></name><name><surname>Gayathri</surname><given-names>N.</given-names></name><name><surname>Ghosh</surname><given-names>B.</given-names></name><name><surname>Dasgupta</surname><given-names>A.</given-names></name></person-group><article-title xml:lang="en">Iron oxide nanoparticles coated with gold: Enhanced magnetic moment due to interfacial effects</article-title><source>Journal of Applied Physics</source><year>2011</year><volume>109</volume><issue>12</issue><fpage>123902</fpage><pub-id pub-id-type="doi">10.1063/1.3596760</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXns1OhsLc%3D</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Size-controlled synthesis of magnetite (Fe3O4) nanoparticles coated with glucose and gluconic acid from a single Fe(III) precursor by a sucrose bifunctional hydrothermal method</article-title><source>J Phys Chem C</source><year>2009</year><volume>113</volume><fpage>16002</fpage><lpage>16008</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtVSgtLrL</pub-id><pub-id pub-id-type="doi">10.1021/jp9038682</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Aneesh</surname><given-names>PM</given-names></name><name><surname>Vanaja</surname><given-names>KA</given-names></name><name><surname>Jayaraj</surname><given-names>MK</given-names></name></person-group><source>Synthesis of ZnO nanoparticles by hydrothermal method</source><year>2007</year><fpage>66390J</fpage></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brust</surname><given-names>Mathias</given-names></name><name><surname>Walker</surname><given-names>Merryl</given-names></name><name><surname>Bethell</surname><given-names>Donald</given-names></name><name><surname>Schiffrin</surname><given-names>David J.</given-names></name><name><surname>Whyman</surname><given-names>Robin</given-names></name></person-group><article-title xml:lang="en">Synthesis of thiol-derivatised gold nanoparticles in a two-phase LiquidâLiquid system</article-title><source>J. Chem. Soc., Chem. Commun.</source><year>1994</year><volume>0</volume><issue>7</issue><fpage>801</fpage><lpage>802</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2cXjtVCmurk%3D</pub-id><pub-id pub-id-type="doi">10.1039/C39940000801</pub-id></mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ban</surname><given-names>Z</given-names></name><name><surname>Barnakov</surname><given-names>YA</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">The synthesis of coreâshell iron@ gold nanoparticles and their characterization</article-title><source>J Mater Chem</source><year>2005</year><volume>15</volume><fpage>4660</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtFKqtrbE</pub-id><pub-id pub-id-type="doi">10.1039/b504304b</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>Y</given-names></name><name><surname>Zhai</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Fabrication of iron oxide core/gold shell submicrometer spheres with nanoscale surface roughness for efficient surface-enhanced Raman scattering</article-title><source>J Phys Chem C</source><year>2009</year><volume>113</volume><fpage>7009</fpage><lpage>7014</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXktFeltr4%3D</pub-id><pub-id pub-id-type="doi">10.1021/jp810561q</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudakovskaya</surname><given-names>PG</given-names></name><name><surname>Beloglazkina</surname><given-names>EK</given-names></name><name><surname>Majouga</surname><given-names>AG</given-names></name><name><surname>Zyk</surname><given-names>NV</given-names></name></person-group><article-title xml:lang="en">Synthesis and characterization of terpyridine-type ligand-protected gold-coated Fe3O4 nanoparticles</article-title><source>Mendeleev Commun</source><year>2010</year><volume>20</volume><fpage>158</fpage><lpage>160</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXos1Krur4%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.mencom.2010.05.012</pub-id></mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>F</given-names></name><name><surname>Balaji</surname><given-names>G</given-names></name><name><surname>Weber</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Influence of gold nanoshell on hyperthermia of super paramagnetic iron oxide nanoparticles (SPIONs)</article-title><source>J Phys Chem C Nanomater Interfaces</source><year>2010</year><volume>114</volume><fpage>19194</fpage><lpage>19201</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtlaitL3J</pub-id><pub-id pub-id-type="doi">10.1021/jp105807r</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>TJ</given-names></name><etal/></person-group><article-title xml:lang="en">Ultrasensitive DNA monitoring by au-Fe 3O 4 nanocomplex</article-title><source>Sensors Actuators B Chem</source><year>2012</year><volume>163</volume><fpage>224</fpage><lpage>232</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XivVemtLs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.snb.2012.01.040</pub-id></mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>Q</given-names></name><etal/></person-group><article-title xml:lang="en">Monodispersed core-shell Fe3O4@Au nanoparticles</article-title><source>J Phys Chem B</source><year>2005</year><volume>109</volume><fpage>21593</fpage><lpage>21601</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXhtFCmtb%2FL</pub-id><pub-id pub-id-type="doi">10.1021/jp0543429</pub-id></mixed-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>I</given-names></name><name><surname>Tung</surname><given-names>LD</given-names></name><name><surname>Maenosono</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis of core-shell gold coated magnetic nanoparticles and their interaction with thiolated DNA</article-title><source>Nanoscale</source><year>2010</year><volume>2</volume><fpage>2624</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsFChs7vJ</pub-id><pub-id pub-id-type="doi">10.1039/c0nr00621a</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahal</surname><given-names>N</given-names></name><name><surname>Chikan</surname><given-names>V</given-names></name><name><surname>Jasinski</surname><given-names>J</given-names></name><name><surname>Leppert</surname><given-names>V</given-names></name></person-group><article-title xml:lang="en">Synthesis of water-soluble ironâ gold alloy nanoparticles</article-title><source>Chem Mater</source><year>2008</year><volume>17</volume><fpage>6389</fpage><lpage>6395</lpage><pub-id pub-id-type="doi">10.1021/cm800389r</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtFGjs7fN</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis of Fe3O4 nanoparticles and their magnetic properties</article-title><source>Procedia Eng</source><year>2012</year><volume>27</volume><fpage>632</fpage><lpage>637</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XlvFOgtLc%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.proeng.2011.12.498</pub-id></mixed-citation></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawal</surname><given-names>R</given-names></name><name><surname>Chawla</surname><given-names>S</given-names></name><name><surname>Pundir</surname><given-names>CS</given-names></name></person-group><article-title xml:lang="en">An electrochemical sulfite biosensor based on gold coated magnetic nanoparticles modified gold electrode</article-title><source>Biosens Bioelectron</source><year>2012</year><volume>31</volume><fpage>144</fpage><lpage>150</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XitlKisQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bios.2011.10.007</pub-id></mixed-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadagouda</surname><given-names>MN</given-names></name><name><surname>Varma</surname><given-names>RS</given-names></name></person-group><article-title xml:lang="en">A greener synthesis of Core (Fe, cu)-shell (au, Pt, Pd, and Ag) nanocrystals using aqueous vitamin C</article-title><source>Cryst Growth Des</source><year>2007</year><volume>7</volume><fpage>2582</fpage><lpage>2587</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXht1OqtLnM</pub-id><pub-id pub-id-type="doi">10.1021/cg070554e</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>T</given-names></name><name><surname>Wani</surname><given-names>IA</given-names></name><name><surname>Ahmed</surname><given-names>J</given-names></name><name><surname>Al-Hartomy</surname><given-names>OA</given-names></name></person-group><article-title xml:lang="en">Effect of gold ion concentration on size and properties of gold nanoparticles in TritonX-100 based inverse microemulsions</article-title><source>Appl Nanosci</source><year>2014</year><volume>4</volume><fpage>491</fpage><lpage>498</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXkslehtr0%3D</pub-id><pub-id pub-id-type="doi">10.1007/s13204-013-0224-y</pub-id></mixed-citation></ref><ref id="CR86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sau</surname><given-names>TK</given-names></name><name><surname>Murphy</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Room temperature, high-yield synthesis of multiple shapes of gold nanoparticles in aqueous solution</article-title><source>J Am Chem Soc</source><year>2004</year><volume>126</volume><fpage>8648</fpage><lpage>8649</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXlsF2msbk%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja047846d</pub-id></mixed-citation></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowack</surname><given-names>B</given-names></name><name><surname>Krug</surname><given-names>HF</given-names></name><name><surname>Height</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">120 years of nanosilver history: implications for policy makers</article-title><source>Environ Sci Technol</source><year>2011</year><volume>45</volume><fpage>1177</fpage><lpage>1183</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXivFCntQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1021/es103316q</pub-id></mixed-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enustun</surname><given-names>BV</given-names></name><name><surname>Turkevich</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Coagulation of colloidal gold</article-title><source>J Am Chem Soc</source><year>1963</year><volume>85</volume><fpage>3317</fpage><lpage>3328</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaF3sXkslahsLo%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja00904a001</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Magnetic core/shell Fe<sub>3</sub>O<sub>4</sub>/Au and Fe<sub>3</sub>O<sub>4</sub>/Au/Ag nanoparticles with tunable plasmonic properties</article-title><source>J Am Chem Soc</source><year>2007</year><volume>129</volume><fpage>8698</fpage><lpage>8699</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXmslyqsrc%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja073057v</pub-id></mixed-citation></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>KR</given-names></name><name><surname>Walter</surname><given-names>DG</given-names></name><name><surname>Natan</surname><given-names>MJ</given-names></name></person-group><article-title xml:lang="en">Seeding of colloidal Au nanoparticle solutions. 2. Improved control of particle size and shape</article-title><source>Chem Mater</source><year>2000</year><volume>12</volume><fpage>306</fpage><lpage>313</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXotFKgt7o%3D</pub-id><pub-id pub-id-type="doi">10.1021/cm980065p</pub-id></mixed-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goon</surname><given-names>IY</given-names></name><name><surname>Lai</surname><given-names>LMH</given-names></name><name><surname>Lim</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Fabrication and dispersion of gold-shell-protected magnetite nanoparticles: systematic control using polyethyleneimine</article-title><source>Chem Mater</source><year>2009</year><volume>21</volume><fpage>673</fpage><lpage>681</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXpt1ejtg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1021/cm8025329</pub-id></mixed-citation></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>CS</given-names></name><name><surname>Hofmann</surname><given-names>C</given-names></name><name><surname>Ali</surname><given-names>TA</given-names></name><etal/></person-group><article-title xml:lang="en">Magneticâplasmonic coreâshell nanoparticles</article-title><source>ACS Nano</source><year>2009</year><volume>3</volume><fpage>1379</fpage><lpage>1388</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXlvVGksL0%3D</pub-id><pub-id pub-id-type="doi">10.1021/nn900118a</pub-id></mixed-citation></ref><ref id="CR93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>JL</given-names></name><name><surname>Fleming</surname><given-names>DA</given-names></name><name><surname>Stone</surname><given-names>MB</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding</article-title><source>Nano Lett</source><year>2004</year><volume>4</volume><fpage>719</fpage><lpage>723</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXit1SqtLo%3D</pub-id><pub-id pub-id-type="doi">10.1021/nl035253f</pub-id></mixed-citation></ref><ref id="CR94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>LL</given-names></name><name><surname>Borwankar</surname><given-names>AU</given-names></name><name><surname>Willsey</surname><given-names>BW</given-names></name><etal/></person-group><article-title xml:lang="en">Growth of textured thin Au coatings on iron oxide nanoparticles with near infrared absorbance</article-title><source>Nanotechnology</source><year>2013</year><volume>24</volume><fpage>025606</fpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC3s3hslymtQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1088/0957-4484/24/2/025606</pub-id></mixed-citation></ref><ref id="CR95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>S</given-names></name><name><surname>Morales</surname><given-names>M</given-names></name><name><surname>Mukherjee</surname><given-names>P</given-names></name><name><surname>Srikanth</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Synthesis and magnetic properties of gold coated iron oxide nanoparticles</article-title><source>J Appl Phys</source><year>2009</year><volume>105</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1063/1.3055268</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXkvVChtQ%3D%3D</pub-id></mixed-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagstaff</surname><given-names>AJ</given-names></name><name><surname>Brown</surname><given-names>SD</given-names></name><name><surname>Holden</surname><given-names>MR</given-names></name><etal/></person-group><article-title xml:lang="en">Cisplatin drug delivery using gold-coated iron oxide nanoparticles for enhanced tumour targeting with external magnetic fields</article-title><source>Inorganica Chim Acta</source><year>2012</year><volume>393</volume><fpage>328</fpage><lpage>333</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xhs1aru7vO</pub-id><pub-id pub-id-type="doi">10.1016/j.ica.2012.05.012</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Brandl</surname><given-names>DW</given-names></name><name><surname>Le</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Nanorice: a hybrid plasmonic nanostructure</article-title><source>Nano Lett</source><year>2006</year><volume>6</volume><fpage>827</fpage><lpage>832</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xit1Wmtrc%3D</pub-id><pub-id pub-id-type="doi">10.1021/nl060209w</pub-id></mixed-citation></ref><ref id="CR98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phan</surname><given-names>CM</given-names></name><name><surname>Nguyen</surname><given-names>HM</given-names></name></person-group><article-title xml:lang="en">Role of capping agent in wet synthesis of nanoparticles</article-title><source>J Phys Chem A</source><year>2017</year><volume>121</volume><fpage>3213</fpage><lpage>3219</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXlvVKjtrw%3D</pub-id><pub-id pub-id-type="doi">10.1021/acs.jpca.7b02186</pub-id></mixed-citation></ref><ref id="CR99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diggins</surname><given-names>FWE</given-names></name></person-group><article-title xml:lang="en">The true history of the discovery of penicillin, with refutation of the misinformation in the literature</article-title><source>Br J Biomed Sci</source><year>1999</year><volume>56</volume><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1MXltVKqs7g%3D</pub-id></mixed-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>G</given-names></name><name><surname>Mitragotri</surname><given-names>S</given-names></name><name><surname>Tong</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Multifunctional nanoparticles for drug delivery and molecular imaging</article-title><source>Annu Rev Biomed Eng</source><year>2013</year><volume>15</volume><fpage>253</fpage><lpage>282</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhsVSqtL%2FM</pub-id><pub-id pub-id-type="doi">10.1146/annurev-bioeng-071812-152409</pub-id></mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>M</given-names></name><name><surname>Deshmukh</surname><given-names>SD</given-names></name><name><surname>Ingle</surname><given-names>AP</given-names></name><etal/></person-group><article-title xml:lang="en">Metal nanoparticles: the protective nanoshield against virus infection</article-title><source>Crit Rev Microbiol</source><year>2014</year><volume>42</volume><fpage>1</fpage><lpage>11</lpage></mixed-citation></ref><ref id="CR102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sreekumar</surname><given-names>TV</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Chandra</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Inherently colored antimicrobial fibers employing silver nanoparticles</article-title><source>J Biomed Nanotechnol</source><year>2009</year><volume>5</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXksFajtL4%3D</pub-id><pub-id pub-id-type="doi">10.1166/jbn.2009.040</pub-id></mixed-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>CA</given-names></name><name><surname>Toothaker</surname><given-names>RD</given-names></name><name><surname>Smith</surname><given-names>AL</given-names></name><name><surname>Slattery</surname><given-names>JT</given-names></name></person-group><article-title xml:lang="en">In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli</article-title><source>Antimicrob Agents Chemother</source><year>1989</year><volume>33</volume><fpage>1046</fpage><lpage>1051</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL1MXkslCltbo%3D</pub-id><pub-id pub-id-type="doi">10.1128/AAC.33.7.1046</pub-id></mixed-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>PanÃ¡Äek</surname><given-names>A</given-names></name><name><surname>KvÃ­tek</surname><given-names>L</given-names></name><name><surname>SmÃ©kalovÃ¡</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Bacterial resistance to silver nanoparticles and how to overcome it</article-title><source>Nat Nanotechnol</source><year>2018</year><volume>13</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/s41565-017-0013-y</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXntVCktA%3D%3D</pub-id></mixed-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtz</surname><given-names>RD</given-names></name><name><surname>Souza Filho a</surname><given-names>G</given-names></name><name><surname>Brocchi</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Development of nanostructured silver vanadates decorated with silver nanoparticles as a novel antibacterial agent</article-title><source>Nanotechnology</source><year>2010</year><volume>21</volume><fpage>185102</fpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC3c3ot1enuw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1088/0957-4484/21/18/185102</pub-id></mixed-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>VC</given-names></name><name><surname>Kharwar</surname><given-names>RN</given-names></name><name><surname>Gange</surname><given-names>AC</given-names></name></person-group><article-title xml:lang="en">Biosynthesis of antimicrobial silver nanoparticles by the endophytic fungus <italic>Aspergillus clavatus</italic></article-title><source>Nanomedicine</source><year>2010</year><volume>5</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhs1Sjs7%2FM</pub-id><pub-id pub-id-type="doi">10.2217/nnm.09.77</pub-id></mixed-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvaraj</surname><given-names>V</given-names></name><name><surname>Nirmala Grace</surname><given-names>A</given-names></name><name><surname>Alagar</surname><given-names>M</given-names></name><name><surname>Hamerton</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Antimicrobial and anticancer efficacy of antineoplastic agent capped gold nanoparticles</article-title><source>J Biomed Nanotechnol</source><year>2010</year><volume>6</volume><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXpvVOrtLg%3D</pub-id><pub-id pub-id-type="doi">10.1166/jbn.2010.1115</pub-id></mixed-citation></ref><ref id="CR108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>MM</given-names></name><name><surname>Fouad</surname><given-names>SA</given-names></name><name><surname>Elshoky</surname><given-names>HA</given-names></name><etal/></person-group><article-title xml:lang="en">Antibacterial effect of gold nanoparticles against Corynebacterium pseudotuberculosis</article-title><source>Int J Vet Sci Med</source><year>2017</year><volume>5</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.ijvsm.2017.02.003</pub-id></mixed-citation></ref><ref id="CR109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamaila</surname><given-names>S</given-names></name><name><surname>Zafar</surname><given-names>N</given-names></name><name><surname>Riaz</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Gold nanoparticles: an efficient antimicrobial agent against enteric bacterial human pathogen</article-title><source>Nanomaterials</source><year>2016</year><volume>6</volume><fpage>71</fpage><pub-id pub-id-type="doi">10.3390/nano6040071</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsFWkt7%2FN</pub-id></mixed-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmon</surname><given-names>SA</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults</article-title><source>Avian Dis</source><year>2000</year><volume>44</volume><fpage>85</fpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD3c7pvF2juw%3D%3D</pub-id><pub-id pub-id-type="doi">10.2307/1592511</pub-id></mixed-citation></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erdogan</surname><given-names>A</given-names></name><name><surname>Rao</surname><given-names>SSC</given-names></name></person-group><article-title xml:lang="en">Small intestinal fungal overgrowth</article-title><source>Curr Gastroenterol Rep</source><year>2015</year><volume>17</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s11894-015-0436-2</pub-id></mixed-citation></ref><ref id="CR112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zietse</surname><given-names>R</given-names></name><name><surname>Zoutendijk</surname><given-names>R</given-names></name><name><surname>Hoorn</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Fluid, electrolyte and acid-base disorders associated with antibiotic therapy</article-title><source>Nat Rev Nephrol</source><year>2009</year><volume>5</volume><fpage>193</fpage><lpage>202</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXjs1ynsbc%3D</pub-id><pub-id pub-id-type="doi">10.1038/nrneph.2009.17</pub-id></mixed-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>RW-Y</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">Silver nanoparticles inhibit hepatitis B virus replication</article-title><source>Antivir Ther</source><year>2008</year><volume>13</volume><fpage>253</fpage><lpage>262</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXlslWmtbk%3D</pub-id></mixed-citation></ref><ref id="CR114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>JV</given-names></name><name><surname>Parkinson</surname><given-names>CV</given-names></name><name><surname>Choi</surname><given-names>YW</given-names></name><etal/></person-group><article-title xml:lang="en">A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation</article-title><source>Nanoscale Res Lett</source><year>2008</year><volume>3</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1007/s11671-008-9128-2</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXnsleht7c%3D</pub-id></mixed-citation></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>HH</given-names></name><name><surname>Ixtepan-Turrent</surname><given-names>L</given-names></name><name><surname>Garza-TreviÃ±o</surname><given-names>EN</given-names></name><name><surname>Rodriguez-Padilla</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture</article-title><source>J Nanobiotechnology</source><year>2010</year><volume>8</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/1477-3155-8-15</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXpt1Gltbg%3D</pub-id></mixed-citation></ref><ref id="CR116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>HH</given-names></name><name><surname>Ayala-NuÃ±ez</surname><given-names>NV</given-names></name><name><surname>Ixtepan-Turrent</surname><given-names>L</given-names></name><name><surname>Rodriguez-Padilla</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Mode of antiviral action of silver nanoparticles against HIV-1</article-title><source>J Nanobiotechnology</source><year>2010</year><volume>8</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1477-3155-8-1</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXht1emtLs%3D</pub-id></mixed-citation></ref><ref id="CR117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baram-Pinto</surname><given-names>D</given-names></name><name><surname>Shukla</surname><given-names>S</given-names></name><name><surname>Gedanken</surname><given-names>A</given-names></name><name><surname>Sarid</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles</article-title><source>Small</source><year>2010</year><volume>6</volume><fpage>1044</fpage><lpage>1050</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXmt1amsr8%3D</pub-id><pub-id pub-id-type="doi">10.1002/smll.200902384</pub-id></mixed-citation></ref><ref id="CR118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Gianvincenzo</surname><given-names>P</given-names></name><name><surname>Marradi</surname><given-names>M</given-names></name><name><surname>MartÃ­nez-Ãvila</surname><given-names>OM</given-names></name><etal/></person-group><article-title xml:lang="en">Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents</article-title><source>Bioorg Med Chem Lett</source><year>2010</year><volume>20</volume><fpage>2718</fpage><lpage>2721</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.03.079</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXkvFeqtbc%3D</pub-id></mixed-citation></ref><ref id="CR119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shionoiri</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Fujimori</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Investigation of the antiviral properties of copper iodide nanoparticles against feline calicivirus</article-title><source>J Biosci Bioeng</source><year>2012</year><volume>113</volume><fpage>580</fpage><lpage>586</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtFOgurnI</pub-id><pub-id pub-id-type="doi">10.1016/j.jbiosc.2011.12.006</pub-id></mixed-citation></ref><ref id="CR120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimori</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Hayata</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Novel antiviral characteristics of nanosized copper(I) iodide particles showing inactivation activity against 2009 pandemic H1N1 influenza virus</article-title><source>Appl Environ Microbiol</source><year>2012</year><volume>78</volume><fpage>951</fpage><lpage>955</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XitVKrtL0%3D</pub-id><pub-id pub-id-type="doi">10.1128/AEM.06284-11</pub-id></mixed-citation></ref><ref id="CR121"><label>121.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Global hepatitis report, 2017</source><year>2017</year></mixed-citation></ref><ref id="CR122"><label>122.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group><source>Progress report 2016, prevent HIV, test and treat all</source><year>2016</year></mixed-citation></ref><ref id="CR123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B</given-names></name><name><surname>Gutteridge</surname><given-names>JMC</given-names></name></person-group><article-title xml:lang="en">Oxygen toxicity, oxygen radicals, transition metals and disease</article-title><source>Biochem J</source><year>1984</year><volume>219</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL2cXhvVKktrk%3D</pub-id><pub-id pub-id-type="doi">10.1042/bj2190001</pub-id></mixed-citation></ref><ref id="CR124"><label>124.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Radiologists RC of</collab><name><surname>Padhani</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>C</given-names></name><name><surname>Carey</surname><given-names>B</given-names></name></person-group><source>Recommendations for cross-sectional imaging in cancer management: computed tomography â CT magnetic resonance imaging â MRI positron emission tomography â PET-CT</source><year>2014</year></mixed-citation></ref><ref id="CR125"><label>125.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>McRobbie</surname><given-names>DW</given-names></name><name><surname>Moore</surname><given-names>EA</given-names></name><name><surname>Graves</surname><given-names>MJ</given-names></name><name><surname>Prince</surname><given-names>MR</given-names></name></person-group><source>MRI from picture to proton</source><year>2006</year><publisher-loc>Cambridge</publisher-loc><publisher-name>Cambridge University Press</publisher-name><pub-id pub-id-type="doi">10.1017/CBO9780511545405</pub-id></mixed-citation></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>KJ</given-names></name><name><surname>Brunberg</surname><given-names>JA</given-names></name><name><surname>Cohan</surname><given-names>RH</given-names></name></person-group><article-title xml:lang="en">Adverse reactions to gadolinium contrast media: a review of 36 cases</article-title><source>Am J Roentgenol</source><year>1996</year><volume>167</volume><fpage>847</fpage><lpage>849</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK28vhs1GksQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.2214/ajr.167.4.8819369</pub-id></mixed-citation></ref><ref id="CR127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>CM</given-names></name><name><surname>Bahn</surname><given-names>I</given-names></name><name><surname>Alexander</surname><given-names>EK</given-names></name><name><surname>Brunelli</surname><given-names>SM</given-names></name></person-group><article-title xml:lang="en">Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism</article-title><source>Arch Intern Med</source><year>2012</year><volume>172</volume><fpage>153</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XivFOisrs%3D</pub-id><pub-id pub-id-type="doi">10.1001/archinternmed.2011.677</pub-id></mixed-citation></ref><ref id="CR128"><label>128.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Park</surname><given-names>S-S</given-names></name><etal/></person-group><source>Synthesis of TiO 2 / SiO 2 nanoparticles in a water-in-carbon-dioxide microemulsion and their photocatalytic activity</source><year>2005</year><fpage>379</fpage><lpage>389</lpage></mixed-citation></ref><ref id="CR129"><label>129.</label><mixed-citation publication-type="other">Blasiak B, Van Veggel FCJM, Tomanek B (2013) Applications of nanoparticles for MRI cancer diagnosis and therapy. J Nanomater 2013:13-15</mixed-citation></ref><ref id="CR130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Gold nanoparticles for photoacoustic imaging</article-title><source>Nanomedicine</source><year>2015</year><volume>10</volume><fpage>299</fpage><lpage>320</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhtlyku7g%3D</pub-id><pub-id pub-id-type="doi">10.2217/nnm.14.169</pub-id></mixed-citation></ref><ref id="CR131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacul</surname><given-names>F</given-names></name><name><surname>van der Molen</surname><given-names>AJ</given-names></name><name><surname>Reimer</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines</article-title><source>Eur Radiol</source><year>2011</year><volume>21</volume><fpage>2527</fpage><lpage>2541</lpage><pub-id pub-id-type="doi">10.1007/s00330-011-2225-0</pub-id></mixed-citation></ref><ref id="CR132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Schooneveld</surname><given-names>MM</given-names></name><name><surname>Cormode</surname><given-names>DP</given-names></name><name><surname>Koole</surname><given-names>R</given-names></name><etal/></person-group><article-title xml:lang="en">A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging</article-title><source>Contrast Media Mol Imaging</source><year>2010</year><volume>5</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1002/cmmi.376</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtFSju7bP</pub-id></mixed-citation></ref><ref id="CR133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheheltani</surname><given-names>R</given-names></name><name><surname>Ezzibdeh</surname><given-names>RM</given-names></name><name><surname>Chhour</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Tunable, biodegradable gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging</article-title><source>Biomaterials</source><year>2016</year><volume>102</volume><fpage>87</fpage><lpage>97</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xps1Wjs70%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.06.015</pub-id></mixed-citation></ref><ref id="CR134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>C</given-names></name><name><surname>Umeda</surname><given-names>Y</given-names></name><name><surname>Ogawa</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer</article-title><source>Nanotechnology</source><year>2010</year><volume>21</volume><fpage>245104</fpage><pub-id pub-id-type="doi">10.1088/0957-4484/21/24/245104</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXosVSntr4%3D</pub-id></mixed-citation></ref><ref id="CR135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umeda</surname><given-names>Y</given-names></name><name><surname>Kojima</surname><given-names>C</given-names></name><name><surname>Harada</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">PEG-attached PAMAM dendrimers encapsulating gold nanoparticles: growing gold nanoparticles in the dendrimers for improvement of their photothermal properties</article-title><source>Bioconjug Chem</source><year>2010</year><volume>21</volume><fpage>1559</fpage><lpage>1564</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXptlClsb0%3D</pub-id><pub-id pub-id-type="doi">10.1021/bc1001399</pub-id></mixed-citation></ref><ref id="CR136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="en">Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques</article-title><source>Biomaterials</source><year>2016</year><volume>108</volume><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.08.048</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsVCqurvP</pub-id></mixed-citation></ref><ref id="CR137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title xml:lang="en">Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain</article-title><source>Nano Lett</source><year>2004</year><volume>4</volume><fpage>1689</fpage><lpage>1692</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXmsVSkt7Y%3D</pub-id><pub-id pub-id-type="doi">10.1021/nl049126a</pub-id></mixed-citation></ref><ref id="CR138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Hwang</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">âSmartâ gold nanoparticles for photoacoustic imaging: an imaging contrast agent responsive to the cancer microenvironment and signal amplification via pH-induced aggregation</article-title><source>Chem Commun</source><year>2016</year><volume>52</volume><fpage>8287</fpage><lpage>8290</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XpvVWqu7k%3D</pub-id><pub-id pub-id-type="doi">10.1039/C6CC03100E</pub-id></mixed-citation></ref><ref id="CR139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashton</surname><given-names>JR</given-names></name><name><surname>Castle</surname><given-names>KD</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Dual-energy CT imaging of tumor liposome delivery after gold nanoparticle-augmented radiation therapy</article-title><source>Theranostics</source><year>2018</year><volume>8</volume><fpage>1782</fpage><lpage>1797</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXit1Srtb%2FE</pub-id><pub-id pub-id-type="doi">10.7150/thno.22621</pub-id></mixed-citation></ref><ref id="CR140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Minghua</given-names></name><name><surname>Wang</surname><given-names>Lihong V.</given-names></name></person-group><article-title xml:lang="en">Photoacoustic imaging in biomedicine</article-title><source>Review of Scientific Instruments</source><year>2006</year><volume>77</volume><issue>4</issue><fpage>041101</fpage><pub-id pub-id-type="doi">10.1063/1.2195024</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xktlaktbw%3D</pub-id></mixed-citation></ref><ref id="CR141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>El-Sayed</surname><given-names>IH</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name><name><surname>El-Sayed</surname><given-names>MA</given-names></name></person-group><article-title xml:lang="en">Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods</article-title><source>J Am Chem Soc</source><year>2006</year><volume>128</volume><fpage>2115</fpage><lpage>2120</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XntFCltQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja057254a</pub-id></mixed-citation></ref><ref id="CR142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>LR</given-names></name><name><surname>Stafford</surname><given-names>RJ</given-names></name><name><surname>Bankson</surname><given-names>JA</given-names></name><etal/></person-group><article-title xml:lang="en">Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance</article-title><source>Proc Natl Acad Sci</source><year>2003</year><volume>100</volume><fpage>13549</fpage><lpage>13554</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXptFOit7k%3D</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2232479100</pub-id></mixed-citation></ref><ref id="CR143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodford</surname><given-names>O</given-names></name><name><surname>Harriman</surname><given-names>A</given-names></name><name><surname>McFarlane</surname><given-names>W</given-names></name><name><surname>Wills</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Dramatic effect of solvent on the rate of photobleaching of organic pyrrole-BF 2 (BOPHY) dyes</article-title><source>ChemPhotoChem</source><year>2017</year><volume>1</volume><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhs1KgtbrP</pub-id><pub-id pub-id-type="doi">10.1002/cptc.201600061</pub-id></mixed-citation></ref><ref id="CR144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashton</surname><given-names>JR</given-names></name><name><surname>Gottlin</surname><given-names>EB</given-names></name><name><surname>Patz</surname><given-names>EF</given-names></name><etal/></person-group><article-title xml:lang="en">A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0206950</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXmvFansLs%3D</pub-id></mixed-citation></ref><ref id="CR145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzea</surname><given-names>C</given-names></name><name><surname>Pacheco</surname><given-names>II</given-names></name><name><surname>Robbie</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Nanomaterials and nanoparticles: sources and toxicity</article-title><source>Biointerphases</source><year>2007</year><volume>2</volume><fpage>MR17</fpage><lpage>MR71</lpage><pub-id pub-id-type="doi">10.1116/1.2815690</pub-id></mixed-citation></ref><ref id="CR146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyano</surname><given-names>DF</given-names></name><name><surname>Goldsmith</surname><given-names>M</given-names></name><name><surname>Solfiell</surname><given-names>DJ</given-names></name><etal/></person-group><article-title xml:lang="en">Nanoparticle hydrophobicity dictates immune response</article-title><source>J Am Chem Soc</source><year>2012</year><volume>134</volume><fpage>3965</fpage><lpage>3967</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XisFShsLg%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja2108905</pub-id></mixed-citation></ref><ref id="CR147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boraschi</surname><given-names>D</given-names></name><name><surname>Duschl</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Nanoparticles and the immune system: safety and effects</article-title><source>Nanoparticles Immune Syst Saf Eff</source><year>2013</year><volume>11</volume><fpage>2621</fpage><lpage>2624</lpage></mixed-citation></ref><ref id="CR148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammers</surname><given-names>T</given-names></name><name><surname>Kiessling</surname><given-names>F</given-names></name><name><surname>Hennink</surname><given-names>WE</given-names></name><name><surname>Storm</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress</article-title><source>J Control Release</source><year>2012</year><volume>161</volume><fpage>175</fpage><lpage>187</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XksVegtbY%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.jconrel.2011.09.063</pub-id></mixed-citation></ref><ref id="CR149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhumkar</surname><given-names>DR</given-names></name><name><surname>Joshi</surname><given-names>HM</given-names></name><name><surname>Sastry</surname><given-names>M</given-names></name><name><surname>Pokharkar</surname><given-names>VB</given-names></name></person-group><article-title xml:lang="en">Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin</article-title><source>Pharm Res</source><year>2007</year><volume>24</volume><fpage>1415</fpage><lpage>1426</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXmvVyqtrk%3D</pub-id><pub-id pub-id-type="doi">10.1007/s11095-007-9257-9</pub-id></mixed-citation></ref><ref id="CR150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>J</given-names></name><name><surname>La</surname><given-names>WG</given-names></name><name><surname>Hwang</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">PH-responsive assembly of gold nanoparticles and âspatiotemporally concertedâ drug release for synergistic cancer therapy</article-title><source>ACS Nano</source><year>2013</year><volume>7</volume><fpage>3388</fpage><lpage>3402</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXkslWntLg%3D</pub-id><pub-id pub-id-type="doi">10.1021/nn400223a</pub-id></mixed-citation></ref><ref id="CR151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SandstrÃ¶m</surname><given-names>P</given-names></name><name><surname>Boncheva</surname><given-names>M</given-names></name><name><surname>Ãkerman</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Nonspecific and thiol-specific binding of DNA to gold nanoparticles</article-title><source>Langmuir</source><year>2003</year><volume>19</volume><fpage>7537</fpage><lpage>7543</lpage><pub-id pub-id-type="doi">10.1021/la034348u</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXltlynurs%3D</pub-id></mixed-citation></ref><ref id="CR152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosi</surname><given-names>NL</given-names></name><name><surname>Giljohann</surname><given-names>DA</given-names></name><name><surname>Thaxton</surname><given-names>CS</given-names></name><etal/></person-group><article-title xml:lang="en">Oligonucleotide-modified gold nanoparticles for intracellular gene regulation</article-title><source>Science</source><year>2006</year><volume>312</volume><fpage>1027</fpage><lpage>1030</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xks1Wqtbo%3D</pub-id><pub-id pub-id-type="doi">10.1126/science.1125559</pub-id></mixed-citation></ref><ref id="CR153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Saha</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Gold nanoparticles for nucleic acid delivery</article-title><source>Mol Ther</source><year>2014</year><volume>22</volume><fpage>1075</fpage><lpage>1083</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXlt1Cqt70%3D</pub-id><pub-id pub-id-type="doi">10.1038/mt.2014.30</pub-id></mixed-citation></ref><ref id="CR154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giljohann</surname><given-names>DA</given-names></name><name><surname>Seferos</surname><given-names>DS</given-names></name><name><surname>Prigodich</surname><given-names>AE</given-names></name><etal/></person-group><article-title xml:lang="en">Gene regulation with polyvalent siRNAânanoparticle conjugates</article-title><source>J Am Chem Soc</source><year>2009</year><volume>131</volume><fpage>2072</fpage><lpage>2073</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXht1Ohu7w%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja808719p</pub-id></mixed-citation></ref><ref id="CR155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonezawa</surname><given-names>T</given-names></name><name><surname>Onoue</surname><given-names>S</given-names></name><name><surname>Kimizuka</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Metal coating of DNA molecules by cationic, metastable gold nanoparticles</article-title><source>Chem Lett</source><year>2002</year><volume>31</volume><fpage>1172</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.1246/cl.2002.1172</pub-id></mixed-citation></ref><ref id="CR156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barron</surname><given-names>N</given-names></name><name><surname>Piskareva</surname><given-names>O</given-names></name><name><surname>Muniyappa</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Targeted genetic modification of cell lines for recombinant protein production</article-title><source>Cytotechnology</source><year>2007</year><volume>53</volume><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXmsFKju7w%3D</pub-id><pub-id pub-id-type="doi">10.1007/s10616-007-9050-y</pub-id></mixed-citation></ref><ref id="CR157"><label>157.</label><mixed-citation publication-type="other">Niidome T, Nakashima K, Takahashi H, Niidome Y (2004) Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cells. Electronic Supplementary Information (ESI) available: A TEM image of the complex at a w/w ratio of 11 Chem Commun 1978. See <ext-link xlink:href="http://xlink.rsc.org/?DOI=b406189f" ext-link-type="url">http://xlink.rsc.org/?DOI=b406189f</ext-link>.</mixed-citation></ref><ref id="CR158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paciotti</surname><given-names>GF</given-names></name><name><surname>Myer</surname><given-names>L</given-names></name><name><surname>Weinreich</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery</article-title><source>Drug Deliv J Deliv Target Ther Agents</source><year>2004</year><volume>11</volume><fpage>169</fpage><lpage>183</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXks1aiurc%3D</pub-id></mixed-citation></ref><ref id="CR159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>V</given-names></name><name><surname>Van Den Bossche</surname><given-names>J</given-names></name><name><surname>Sherman</surname><given-names>DM</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells</article-title><source>Bioconjug Chem</source><year>2006</year><volume>17</volume><fpage>603</fpage><lpage>609</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XktVertrc%3D</pub-id><pub-id pub-id-type="doi">10.1021/bc050335b</pub-id></mixed-citation></ref><ref id="CR160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>L</given-names></name><name><surname>Jo</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Synthesis and evaluation of doxorubicin-loaded gold nanoparticles for tumor-targeted drug delivery</article-title><source>Bioconjug Chem</source><year>2018</year><volume>29</volume><fpage>420</fpage><lpage>430</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXitVSitbjJ</pub-id><pub-id pub-id-type="doi">10.1021/acs.bioconjchem.7b00756</pub-id></mixed-citation></ref><ref id="CR161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalimuthu</surname><given-names>K</given-names></name><name><surname>Lubin</surname><given-names>B-C</given-names></name><name><surname>Bazylevich</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells</article-title><source>J Nanobiotechnology</source><year>2018</year><volume>16</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/s12951-018-0362-1</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXjt1Oit7g%3D</pub-id></mixed-citation></ref><ref id="CR162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Progress and perspectives on targeting nanoparticles for brain drug delivery</article-title><source>Acta Pharm Sin B</source><year>2016</year><volume>6</volume><fpage>268</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2016.05.013</pub-id></mixed-citation></ref><ref id="CR163"><label>163.</label><mixed-citation publication-type="other">Rosenblum D, Joshi N, Tao W et al (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun 9:1-12</mixed-citation></ref><ref id="CR164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>AD</given-names></name><name><surname>Claypool</surname><given-names>SE</given-names></name><name><surname>Liu</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">The smart targeting of nanoparticles</article-title><source>Curr Pharm Des</source><year>2013</year><volume>19</volume><fpage>6315</fpage><lpage>6329</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhsFyrs73P</pub-id><pub-id pub-id-type="doi">10.2174/13816128113199990375</pub-id></mixed-citation></ref><ref id="CR165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fay</surname><given-names>F</given-names></name><name><surname>Scott</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Antibody-targeted nanoparticles for cancer therapy</article-title><source>Immunotherapy</source><year>2011</year><volume>3</volume><fpage>381</fpage><lpage>394</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXjtFSkur0%3D</pub-id><pub-id pub-id-type="doi">10.2217/imt.11.5</pub-id></mixed-citation></ref><ref id="CR166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>T</given-names></name><name><surname>Mulholland</surname><given-names>P</given-names></name><name><surname>Chester</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Antibody-targeted nanoparticles for cancer treatment</article-title><source>Immunotherapy</source><year>2016</year><volume>8</volume><fpage>941</fpage><lpage>958</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhtFWhsrjP</pub-id><pub-id pub-id-type="doi">10.2217/imt.16.11</pub-id></mixed-citation></ref><ref id="CR167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okur</surname><given-names>AC</given-names></name><name><surname>Erkoc</surname><given-names>P</given-names></name><name><surname>Kizilel</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles</article-title><source>Colloids Surf B Biointerfaces</source><year>2016</year><volume>147</volume><fpage>191</fpage><lpage>200</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhtlWju7zE</pub-id><pub-id pub-id-type="doi">10.1016/j.colsurfb.2016.08.005</pub-id></mixed-citation></ref><ref id="CR168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>A</given-names></name><name><surname>Ndifon</surname><given-names>C</given-names></name><name><surname>Lui</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Tumor-homing peptides as tools for targeted delivery of payloads to the placenta</article-title><source>Sci Adv</source><year>2016</year><volume>2</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1126/sciadv.1600349</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXmtF2is78%3D</pub-id></mixed-citation></ref><ref id="CR169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardridge</surname><given-names>WM</given-names></name></person-group><article-title xml:lang="en">Bloodâbrain barrier delivery</article-title><source>Drug Discov Today</source><year>2007</year><volume>12</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhsFOjsA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.drudis.2006.10.013</pub-id></mixed-citation></ref><ref id="CR170"><label>170.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwenin</surname><given-names>VV</given-names></name><name><surname>Gwenin</surname><given-names>CD</given-names></name><name><surname>Kalaji</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Colloidal gold modified with a genetically engineered nitroreductase: toward a novel enzyme delivery system for cancer prodrug therapy</article-title><source>Langmuir</source><year>2011</year><volume>27</volume><fpage>14300</fpage><lpage>14307</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtlCmtLfF</pub-id><pub-id pub-id-type="doi">10.1021/la202951p</pub-id></mixed-citation></ref><ref id="CR171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obaidat</surname><given-names>I</given-names></name><name><surname>Issa</surname><given-names>B</given-names></name><name><surname>Haik</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Magnetic properties of magnetic nanoparticles for efficient hyperthermia</article-title><source>Nanomaterials</source><year>2015</year><volume>5</volume><fpage>63</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.3390/nano5010063</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXht1Slsb0%3D</pub-id></mixed-citation></ref><ref id="CR172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BÃ¸dker</surname><given-names>F</given-names></name><name><surname>MÃ¸rup</surname><given-names>S</given-names></name><name><surname>Linderoth</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Surface effects in metallic iron nanoparticles</article-title><source>Phys Rev Lett</source><year>1994</year><volume>72</volume><fpage>282</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.72.282</pub-id></mixed-citation></ref><ref id="CR173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mody</surname><given-names>VV</given-names></name><name><surname>Cox</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Magnetic nanoparticle drug delivery systems for targeting tumor</article-title><source>Appl Nanosci</source><year>2014</year><volume>4</volume><fpage>385</fpage><lpage>392</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXkslekurs%3D</pub-id><pub-id pub-id-type="doi">10.1007/s13204-013-0216-y</pub-id></mixed-citation></ref><ref id="CR174"><label>174.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Donaldson</surname><given-names>JD</given-names></name><name><surname>Beyersmann</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Cobalt and cobalt compounds</article-title><source>Ullmannâs encyclopedia of industrial chemistry</source><year>2005</year><publisher-loc>Weinheim</publisher-loc><publisher-name>Wiley-VCH Verlag GmbH &amp; Co. KGaA</publisher-name><fpage>467</fpage><lpage>497</lpage></mixed-citation></ref><ref id="CR175"><label>175.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crossgrove</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Manganese toxicity upon overexposure</article-title><source>NMR Biomed</source><year>2004</year><volume>17</volume><fpage>544</fpage><lpage>553</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXht1Knsr0%3D</pub-id><pub-id pub-id-type="doi">10.1002/nbm.931</pub-id></mixed-citation></ref><ref id="CR176"><label>176.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>HL</given-names></name><name><surname>Gustafsson</surname><given-names>J</given-names></name><name><surname>Cronholm</surname><given-names>P</given-names></name><name><surname>MÃ¶ller</surname><given-names>L</given-names></name></person-group><article-title xml:lang="en">Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size</article-title><source>Toxicol Lett</source><year>2009</year><volume>188</volume><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXmtVKhsro%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.toxlet.2009.03.014</pub-id></mixed-citation></ref><ref id="CR177"><label>177.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto</surname><given-names>K</given-names></name><name><surname>Garza</surname><given-names>KM</given-names></name><name><surname>Murr</surname><given-names>LE</given-names></name></person-group><article-title xml:lang="en">Cytotoxic effects of aggregated nanomaterials</article-title><source>Acta Biomater</source><year>2007</year><volume>3</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtVarsrbE</pub-id><pub-id pub-id-type="doi">10.1016/j.actbio.2006.11.004</pub-id></mixed-citation></ref><ref id="CR178"><label>178.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunner</surname><given-names>TJ</given-names></name><name><surname>Wick</surname><given-names>P</given-names></name><name><surname>Manser</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility</article-title><source>Environ Sci Technol</source><year>2006</year><volume>40</volume><fpage>4374</fpage><lpage>4381</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xit1Wms7g%3D</pub-id><pub-id pub-id-type="doi">10.1021/es052069i</pub-id></mixed-citation></ref><ref id="CR179"><label>179.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chia</surname><given-names>SL</given-names></name><name><surname>Leong</surname><given-names>DT</given-names></name></person-group><article-title xml:lang="en">Reducing ZnO nanoparticles toxicity through silica coating</article-title><source>Heliyon</source><year>2016</year><volume>2</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2016.e00177</pub-id></mixed-citation></ref><ref id="CR180"><label>180.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mine</surname><given-names>E</given-names></name><name><surname>Yamada</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Direct coating of gold nanoparticles with silica by a seeded polymerization technique</article-title><source>J Colloid Interface Sci</source><year>2003</year><volume>264</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXmtFagtL8%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9797(03)00422-3</pub-id></mixed-citation></ref><ref id="CR181"><label>181.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerruti</surname><given-names>MG</given-names></name><name><surname>Sauthier</surname><given-names>M</given-names></name><name><surname>Leonard</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Gold and silica-coated gold nanoparticles as thermographic labels for DNA detection</article-title><source>Anal Chem</source><year>2006</year><volume>78</volume><fpage>3282</fpage><lpage>3288</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XjsFKitL8%3D</pub-id><pub-id pub-id-type="doi">10.1021/ac0600555</pub-id></mixed-citation></ref><ref id="CR182"><label>182.</label><mixed-citation publication-type="other">Kobayashi Y, Nagasu R, Shibuya K et al (2014) Synthesis of a colloid solution of silica-coated gold nanoparticles for X-ray imaging applications. J Nanopart Res 16:1-13</mixed-citation></ref><ref id="CR183"><label>183.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tural</surname><given-names>B</given-names></name><name><surname>Ãzkan</surname><given-names>N</given-names></name><name><surname>Volkan</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Preparation and characterization of polymer coated superparamagnetic magnetite nanoparticle agglomerates</article-title><source>J Phys Chem Solids</source><year>2009</year><volume>70</volume><fpage>860</fpage><lpage>866</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXmvFakur4%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.jpcs.2009.04.007</pub-id></mixed-citation></ref><ref id="CR184"><label>184.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Dave</surname><given-names>RN</given-names></name><name><surname>Pfeffer</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Polymer coating/encapsulation of nanoparticles using a supercritical anti-solvent process</article-title><source>J Supercrit Fluids</source><year>2004</year><volume>28</volume><fpage>85</fpage><lpage>99</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXpt1Krt7c%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0896-8446(03)00011-1</pub-id></mixed-citation></ref><ref id="CR185"><label>185.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Properties of core-shell Ni-Au nanoparticles synthesized through a redox-transmetalation method in reverse microemulsion</article-title><source>Chem Mater</source><year>2007</year><volume>19</volume><fpage>3399</fpage><lpage>3405</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXmt12isLc%3D</pub-id><pub-id pub-id-type="doi">10.1021/cm070182x</pub-id></mixed-citation></ref><ref id="CR186"><label>186.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jana</surname><given-names>NR</given-names></name></person-group><article-title xml:lang="en">Silver coated gold nanoparticles as new surface enhanced Raman substrate at low analyte concentration</article-title><source>Analyst</source><year>2003</year><volume>128</volume><fpage>954</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXltVWnsbw%3D</pub-id><pub-id pub-id-type="doi">10.1039/b302409a</pub-id></mixed-citation></ref><ref id="CR187"><label>187.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dierks</surname><given-names>S</given-names></name></person-group><source>Gold âMSDSâ electronic space products international</source><year>2005</year><fpage>1</fpage><lpage>6</lpage></mixed-citation></ref><ref id="CR188"><label>188.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>JW</given-names></name></person-group><article-title xml:lang="en">History of the medical use of silver</article-title><source>Surg Infect</source><year>2009</year><volume>10</volume><fpage>289</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1089/sur.2008.9941</pub-id></mixed-citation></ref><ref id="CR189"><label>189.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>DE</given-names></name><name><surname>Barillo</surname><given-names>DJ</given-names></name></person-group><article-title xml:lang="en">Silver in medicine: the basic science</article-title><source>Burns</source><year>2014</year><volume>40</volume><fpage>S9</fpage><lpage>S18</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2014.09.010</pub-id></mixed-citation></ref><ref id="CR190"><label>190.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shubayev</surname><given-names>VI</given-names></name><name><surname>Pisanic</surname><given-names>TR</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Magnetic nanoparticles for theragnostics</article-title><source>Adv Drug Deliv Rev</source><year>2009</year><volume>61</volume><fpage>467</fpage><lpage>477</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXmsF2js7s%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.addr.2009.03.007</pub-id></mixed-citation></ref><ref id="CR191"><label>191.</label><mixed-citation publication-type="other">Gwenin VV, Gwenin CD, Kalaji M (2009) Gold coated magnetic particles enabling nitroreductase delivery to cancer cells. European Union Patent PCT/EP2010/062871</mixed-citation></ref><ref id="CR192"><label>192.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBain</surname><given-names>SC</given-names></name><name><surname>Yiu</surname><given-names>HHP</given-names></name><name><surname>Dobson</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Magnetic nanoparticles for gene and drug delivery</article-title><source>Int J Nanomedicine</source><year>2008</year><volume>3</volume><fpage>169</fpage><lpage>180</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXps1Wjt7s%3D</pub-id></mixed-citation></ref><ref id="CR193"><label>193.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veiseh</surname><given-names>O</given-names></name><name><surname>Gunn</surname><given-names>JW</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging</article-title><source>Adv Drug Deliv Rev</source><year>2010</year><volume>62</volume><fpage>284</fpage><lpage>304</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXit1Ont7s%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.addr.2009.11.002</pub-id></mixed-citation></ref><ref id="CR194"><label>194.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayal</surname><given-names>S</given-names></name><name><surname>Ramanujan</surname><given-names>RV</given-names></name></person-group><article-title xml:lang="en">Anti-Cancer drug loaded ironâgold coreâshell nanoparticles (Fe@Au) for magnetic drug targeting</article-title><source>J Nanosci Nanotechnol</source><year>2010</year><volume>10</volume><fpage>5527</fpage><lpage>5539</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtlCqt7zN</pub-id><pub-id pub-id-type="doi">10.1166/jnn.2010.2461</pub-id></mixed-citation></ref><ref id="CR195"><label>195.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Magnetic nanoparticles for drug delivery</article-title><source>Drug Dev Res</source><year>2006</year><volume>67</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XltF2msb4%3D</pub-id><pub-id pub-id-type="doi">10.1002/ddr.20067</pub-id></mixed-citation></ref><ref id="CR196"><label>196.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arruebo</surname><given-names>M</given-names></name><name><surname>FernÃ¡ndez-Pacheco</surname><given-names>R</given-names></name><name><surname>Ibarra</surname><given-names>MR</given-names></name><name><surname>SantamarÃ­a</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Magnetic nanoparticles for drug delivery</article-title><source>Nanotoday</source><year>2007</year><volume>2</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/S1748-0132(07)70084-1</pub-id></mixed-citation></ref><ref id="CR197"><label>197.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhana</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Near-infrared-absorbing gold nanopopcorns with iron oxide cluster core for magnetically amplified photothermal and photodynamic cancer therapy</article-title><source>ACS Appl Mater Interfaces</source><year>2015</year><volume>7</volume><fpage>11637</fpage><lpage>11647</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXot1ehu7k%3D</pub-id><pub-id pub-id-type="doi">10.1021/acsami.5b02741</pub-id></mixed-citation></ref><ref id="CR198"><label>198.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abadeer</surname><given-names>NS</given-names></name><name><surname>Murphy</surname><given-names>CJ</given-names></name></person-group><article-title xml:lang="en">Recent progress in cancer thermal therapy using gold nanoparticles</article-title><source>J Phys Chem C</source><year>2016</year><volume>120</volume><fpage>4691</fpage><lpage>4716</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xitleqs7Y%3D</pub-id><pub-id pub-id-type="doi">10.1021/acs.jpcc.5b11232</pub-id></mixed-citation></ref><ref id="CR199"><label>199.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirui</surname><given-names>Dickson K</given-names></name><name><surname>Rey</surname><given-names>Diego A</given-names></name><name><surname>Batt</surname><given-names>Carl A</given-names></name></person-group><article-title>Gold hybrid nanoparticles for targeted phototherapy and cancer imaging</article-title><source>Nanotechnology</source><year>2010</year><volume>21</volume><issue>10</issue><fpage>105105</fpage><pub-id pub-id-type="doi">10.1088/0957-4484/21/10/105105</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXjtV2isrk%3D</pub-id></mixed-citation></ref><ref id="CR200"><label>200.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lal</surname><given-names>S</given-names></name><name><surname>Clare</surname><given-names>SE</given-names></name><name><surname>Halas</surname><given-names>NJ</given-names></name></person-group><article-title xml:lang="en">Photothermal therapy : impending clinical impact</article-title><source>Acc Chem Res</source><year>2008</year><volume>41</volume><fpage>1842</fpage><lpage>1851</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtl2ltbzL</pub-id><pub-id pub-id-type="doi">10.1021/ar800150g</pub-id></mixed-citation></ref><ref id="CR201"><label>201.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotiriou</surname><given-names>GA</given-names></name><name><surname>Starsich</surname><given-names>F</given-names></name><name><surname>Dasargyri</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Photothermal killing of cancer cells by the controlled plasmonic coupling of silica-coated Au/Fe2O3 nanoaggregates</article-title><source>Adv Funct Mater</source><year>2014</year><volume>24</volume><fpage>2818</fpage><lpage>2827</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXmtVCkuw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1002/adfm.201303416</pub-id></mixed-citation></ref><ref id="CR202"><label>202.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S-J</given-names></name><name><surname>Jarrett</surname><given-names>BR</given-names></name><name><surname>Louie</surname><given-names>AY</given-names></name><name><surname>Kauzlarich</surname><given-names>SM</given-names></name></person-group><article-title xml:lang="en">Gold-coated iron nanoparticles: a novel magnetic resonance agent for <italic>T</italic><sub>1</sub> and <italic>T</italic><sub>2</sub> weighted imaging</article-title><source>Nanotechnology</source><year>2006</year><volume>17</volume><fpage>640</fpage><lpage>644</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28Xis1yhsrk%3D</pub-id><pub-id pub-id-type="doi">10.1088/0957-4484/17/3/004</pub-id></mixed-citation></ref><ref id="CR203"><label>203.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy</article-title><source>Biomaterials</source><year>2012</year><volume>33</volume><fpage>2215</fpage><lpage>2222</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xnt1egtA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2011.11.069</pub-id></mixed-citation></ref><ref id="CR204"><label>204.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajkumar</surname><given-names>S</given-names></name><name><surname>Prabaharan</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Multi-functional core-shell Fe3O4@ Au nanoparticles for cancer diagnosis and therapy</article-title><source>Colloids Surf B Biointerfaces</source><year>2019</year><volume>174</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.11.004</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXit1ymsbbI</pub-id></mixed-citation></ref><ref id="CR205"><label>205.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izadiyan</surname><given-names>Z</given-names></name><name><surname>Shameli</surname><given-names>K</given-names></name><name><surname>Miyake</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Green fabrication of biologically active magnetic core-shell Fe3O4/Au nanoparticles and their potential anticancer effect</article-title><source>Mater Sci Eng C</source><year>2019</year><volume>96</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXit1Wit7fL</pub-id><pub-id pub-id-type="doi">10.1016/j.msec.2018.11.008</pub-id></mixed-citation></ref><ref id="CR206"><label>206.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Magnetic targeting core/shell Fe3O4/Au nanoparticles for magnetic resonance/photoacoustic dual-modal imaging</article-title><source>Mater Sci Eng C</source><year>2019</year><volume>98</volume><fpage>545</fpage><lpage>549</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXhtFSitLs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.msec.2019.01.013</pub-id></mixed-citation></ref><ref id="CR207"><label>207.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Searle</surname><given-names>PF</given-names></name><name><surname>Chen</surname><given-names>MJ</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Nitroreductase: a prodrug-activating enzyme for cancer gene therapy</article-title><source>Clin Exp Pharmacol Physiol</source><year>2004</year><volume>31</volume><fpage>811</fpage><lpage>816</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXhtVCjt73O</pub-id><pub-id pub-id-type="doi">10.1111/j.1440-1681.2004.04085.x</pub-id></mixed-citation></ref><ref id="CR208"><label>208.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>JG</given-names></name><name><surname>Mautner</surname><given-names>V</given-names></name><etal/></person-group><article-title xml:lang="en">A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1984</article-title><source>Mol Ther</source><year>2009</year><volume>17</volume><fpage>1292</fpage><lpage>1299</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXksVyitbs%3D</pub-id><pub-id pub-id-type="doi">10.1038/mt.2009.80</pub-id></mixed-citation></ref><ref id="CR209"><label>209.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>DH</given-names></name><name><surname>Mautner</surname><given-names>V</given-names></name><name><surname>Mirza</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer</article-title><source>J Clin Oncol</source><year>2004</year><volume>22</volume><fpage>1546</fpage><lpage>1552</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXpsVWmtbk%3D</pub-id><pub-id pub-id-type="doi">10.1200/JCO.2004.10.005</pub-id></mixed-citation></ref><ref id="CR210"><label>210.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bagshawe</surname><given-names>KD</given-names></name><etal/></person-group><person-group person-group-type="editor"><name><surname>Valentino</surname><given-names>S</given-names></name><name><surname>Borchardt</surname><given-names>R</given-names></name><name><surname>Hageman</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Antibody-directed enzyme prodrug therapy professor</article-title><source>Prodrugs: challenges and rewards</source><year>2005</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>526</fpage><lpage>536</lpage></mixed-citation></ref><ref id="CR211"><label>211.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>SK</given-names></name><name><surname>Chester</surname><given-names>KA</given-names></name><name><surname>Bagshawe</surname><given-names>KD</given-names></name></person-group><article-title xml:lang="en">Antibody-directed enzyme prodrug therapy (ADEPT)</article-title><source>Handb Ther Antibodies Second Ed</source><year>2014</year><volume>1</volume><issue>4</issue><fpage>475</fpage><lpage>486</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXpslGms74%3D</pub-id></mixed-citation></ref><ref id="CR212"><label>212.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwenin</surname><given-names>CD</given-names></name><name><surname>Kalaji</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>PA</given-names></name><name><surname>Jones</surname><given-names>RM</given-names></name></person-group><article-title xml:lang="en">The orientationally controlled assembly of genetically modified enzymes in an amperometric biosensor</article-title><source>Biosens Bioelectron</source><year>2007</year><volume>22</volume><fpage>2869</fpage><lpage>2875</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXlsFKnu7w%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bios.2006.12.012</pub-id></mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>(o/w)</term><def><p id="Par2">Oil-in-water</p></def></def-item><def-item><term>(w/o)</term><def><p id="Par3">Water-in-oil</p></def></def-item><def-item><term>(w/sc-CO<sub>2</sub>)</term><def><p id="Par4">Water-in-supercritical CO<sub>2</sub></p></def></def-item><def-item><term>AgNP</term><def><p id="Par5">Silver nanoparticle</p></def></def-item><def-item><term>Ag-PS-NPs</term><def><p id="Par6">Polysaccharide-coated silver nanoparticles</p></def></def-item><def-item><term>Au-Fe<sub>3</sub>O<sub>4</sub></term><def><p id="Par7">Gold-coated iron oxide nanoparticle</p></def></def-item><def-item><term>Au-MES</term><def><p id="Par8">Mercaptoethane sulfate-coated gold nanoparticle</p></def></def-item><def-item><term>AuNP</term><def><p id="Par9">Gold nanoparticle</p></def></def-item><def-item><term>Au-PEG-TNF</term><def><p id="Par10">Polyethylene glycol-coated tumor necrosis factor-loaded gold nanoparticles</p></def></def-item><def-item><term>CT</term><def><p id="Par11">Computed tomography</p></def></def-item><def-item><term>CTAB</term><def><p id="Par12">Cetyltrimethylammonium bromide</p></def></def-item><def-item><term>CuI NPs</term><def><p id="Par13">Copper-iodine nanoparticles</p></def></def-item><def-item><term>DNA</term><def><p id="Par14">Deoxyribonucleic acid</p></def></def-item><def-item><term>FCV</term><def><p id="Par15">Feline calicivirus</p></def></def-item><def-item><term>FR</term><def><p id="Par16">Folate receptor</p></def></def-item><def-item><term>Gp120</term><def><p id="Par17">Glycoprotein 120</p></def></def-item><def-item><term>H1N1</term><def><p id="Par18">Influenza A of swine origin</p></def></def-item><def-item><term>HBV</term><def><p id="Par19">Hepatitis B virus</p></def></def-item><def-item><term>HIV</term><def><p id="Par20">Human immune-deficiency virus-1</p></def></def-item><def-item><term>HSV-1</term><def><p id="Par21">Herpes simplex virus 1</p></def></def-item><def-item><term>KB-3-1</term><def><p id="Par22">Head and neck cancer</p></def></def-item><def-item><term>MC-38</term><def><p id="Par23">Colon carcinoma</p></def></def-item><def-item><term>MPV</term><def><p id="Par24">Monkeypox virus</p></def></def-item><def-item><term>MRI</term><def><p id="Par25">Magnetic resonance imaging</p></def></def-item><def-item><term>PA</term><def><p id="Par26">Photoacoustic imaging</p></def></def-item><def-item><term>PEG</term><def><p id="Par27">Polyethylene glycol</p></def></def-item><def-item><term>PVP-AgNP</term><def><p id="Par28">Polyvinylpyrrolidone-coated silver nanoparticle</p></def></def-item><def-item><term>RNA</term><def><p id="Par29">Ribonucleic acid</p></def></def-item><def-item><term>ROS</term><def><p id="Par30">Reactive oxygen species</p></def></def-item><def-item><term>siRNA</term><def><p id="Par31">Small interfering ribonucleic acid</p></def></def-item><def-item><term>Sk-BR-3</term><def><p id="Par32">Breast cancer</p></def></def-item><def-item><term>SPECT</term><def><p id="Par33">Single-photon emission computed tomography</p></def></def-item><def-item><term>TNF</term><def><p id="Par34">Tumor necrosis factor</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisherâs Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Materials Science</facet-value><facet-value count="1">Molecular Medicine</facet-value><facet-value count="1">Nanochemistry</facet-value><facet-value count="1">Nanoscale Science and Technology</facet-value><facet-value count="1">Nanotechnology</facet-value><facet-value count="1">Nanotechnology and Microengineering</facet-value></facet><facet name="keyword"><facet-value count="1">Drug delivery</facet-value><facet-value count="1">Nanomedicine</facet-value><facet-value count="1">Nanoparticle</facet-value><facet-value count="1">Nanoparticle synthesis</facet-value></facet><facet name="pub"><facet-value count="1">Nanoscale Research Letters</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">United Kingdom</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
